sertraline has been researched along with Depression, Endogenous in 546 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (1.28) | 18.7374 |
| 1990's | 237 (43.41) | 18.2507 |
| 2000's | 193 (35.35) | 29.6817 |
| 2010's | 100 (18.32) | 24.3611 |
| 2020's | 9 (1.65) | 2.80 |
| Authors | Studies |
|---|---|
| Komarov, SD; Severtsev, VV; Vdovin, AS; Vinnikova, MA | 1 |
| Abramkin, AA; Glukhova, SI; Kovalevskaya, OB; Lisitsyna, TA; Nasonov, EL; Seravina, OF; Veltishchev, DY | 1 |
| Petelin, DS; Volel', BA | 1 |
| Ades, A; Amos, R; Araya, R; Brabyn, S; Button, KS; Churchill, R; Derrick, C; Dowrick, C; Duffy, L; Fawsitt, C; Gilbody, S; Hollingworth, W; Jones, V; Kendrick, T; Kessler, D; Khan, N; Kounali, D; Lanham, P; Lewis, G; Pervin, J; Peters, TJ; Riozzie, D; Salaminios, G; Thomas, L; Welton, NJ; Wiles, N; Woodhouse, R | 1 |
| Abbaszadegan, MR; Ahmadimanesh, M; Akhondpour Manteghi, A; Behdani, F; Etemad, L; Farid Hosseini, F; Ghahremani, MH; Jowsey, P; Moallem, SA; Moallem, SMH; Mohammadpour, AH; Morshedi Rad, D; Shabani Behbahani, F | 1 |
| Digala, LP; Lucchese, S | 1 |
| Orgeta, V; Stafford, J; Tuijt, R; Verdaguer, ES | 1 |
| Wilson, C | 1 |
| Bagheri, H; Garcia, C; Guerrero, F; Maurel-Ribes, A; Payrastre, B; Strumia, M | 1 |
| Hui, A | 1 |
| Blennow, M; Blomdahl-Wetterholm, M; Gustafsson, LL; Heinonen, E; Hovstadius, M; Nasiell, J; Pohanka, A; Wide, K | 1 |
| Liu, W; Qin, J | 1 |
| Blesl, C; Holl, A; Mörkl, S; Painold, A; Schmiedhofer, F; Tmava, A; Wurm, WE | 1 |
| Emilsson, JF; Eriksson, E; Hieronymus, F; Lisinski, A; Näslund, J; Nilsson, S | 1 |
| Cunnane, JG; Lucking, AN; Mittal, S | 1 |
| Gangadhar, P; Rafeeque, PA; Sreeraj, VS; Uvais, NA | 1 |
| Bocharnikova, EN; Druzhkova, TA; Gersamia, AG; Gotovtseva, GN; Gudkova, AA; Guekht, AB; Menshikova, AA; Pavlova, EL; Semenov, RV | 1 |
| Aldinio, V; Bullrich, MB; Da Prat, G; Gatto, EM; Parisi, V; Persi, G; Rojas, G; Sanchez, P | 1 |
| Beyer, JL; Johnson, KG | 1 |
| Andrade, C; Anilkumar, TV; Indu, PS; Kumar, KA; Remadevi, S; Sarma, PS; Vijayakumar, K | 1 |
| Baricault, B; Lapeyre-Mestre, M; Montastruc, F; Montastruc, JL; Raynaud, JP; Revet, A | 1 |
| Chang, L; Chen, J; Hashimoto, K; Ishima, T; Ma, M; Pu, Y; Ren, Q; Xiong, Z; Zhang, K | 1 |
| Brummelte, S; Kott, JM; Mooney-Leber, SM | 1 |
| Hollon, SD | 1 |
| Chen, L; Cheng, S; Guo, S; Xu, H | 1 |
| Baldwin, DS; Chen, X; Fu, J; Fu, T; Gao, Z; Hou, R; Liu, Q; Liu, Y; Pan, M; Tang, Z; Ye, G; Zhu, F | 1 |
| Chen, P; Fu, Q; Gao, C; Liu, Z; Zhou, Q | 1 |
| Ilias, I; Karaiskos, D; Liappas, I; Paparrigopoulos, T; Tzavellas, E | 1 |
| Garcon, E; Johnert, LC; Pimontel, MA; Reinlieb, ME; Roose, SP; Sneed, JR | 1 |
| Corruble, E; Demyttenaere, K; Hale, A; Kasper, S; Picarel-Blanchot, F; Quera-Salva, MA | 1 |
| Manglick, M; Melvin, G; Rajaratnam, SM; Taffe, J; Tonge, B | 1 |
| Desai, KM; Farrah, R; Glick, RM; Lovett, E; Low Dog, T | 1 |
| Blow, FC; Bohnert, AS; Ganoczy, D; Kales, HC; Nallamothu, BK; Pfeiffer, PN; Zivin, K | 1 |
| Filov, I; Gerazova, VP; Marinov, P; Novotni, A; Ristevska-Dimitrovska, G; Shishkov, R; Stefanovski, B; Vujovik, V | 1 |
| Benseñor, IM; Brunoni, AR; Gattaz, WF; Lotufo, PA; Machado-Vieira, R; Teixeira, AL; Valiengo, L; Vieira, EL; Zarate, CA | 1 |
| Hao, Y; Jia, F; Li, X; Liu, W; Ren, Y; Wing, YK; Zhang, B; Zhou, P | 1 |
| Karale, M; Lunawat, VK | 1 |
| Cooper, N; Gross, JJ; McRae, K; Rekshan, W; Williams, LM | 1 |
| Bhandary, RP; Munoli, RN; Praharaj, SK; Sinha, S; Udupa, S | 1 |
| Becker, T; Koesters, M; Ma, Y; Zhang, Y | 1 |
| Cai, H; Gong, H; Jiang, P; Li, H; Liu, Y; Tang, M; Zhang, L | 1 |
| Arnow, BA; Boyce, PM; Day, CV; DeBattista, C; Etkin, A; Harris, AW; John Rush, A; Rekshan, W; Schatzberg, AF; Williams, LM | 1 |
| Bogen, DL; Ciolino, JD; Hoxha, D; Pinheiro, E; Wisner, KL | 1 |
| Arnow, BA; Blasey, C; Etkin, A; Kulkarni, J; Luther, JF; Palmer, DM; Rekshan, W; Rush, AJ; Schatzberg, AF; Williams, LM | 1 |
| Appt, SE; Clarkson, TB; Register, TC; Shively, CA | 1 |
| Antoniou, K; Dalla, C; Kafetzopoulos, V; Kokras, N; Mikail, HG; Papadopoulou-Daifoti, Z | 1 |
| Bourland, JD; Clark, A; Daunais, JB; Johnston, WD; Jones, SR; Kraft, RA; Massey, A; Neely, D; Shively, CA; Uberseder, B; Willard, SL; Williamson, JD | 1 |
| McMahon, FJ | 1 |
| Chen, S; Conwell, Y; He, J; Lu, N; Wu, J | 1 |
| Matheiken, S | 1 |
| Avramescu, ET; Dănciulescu Miulescu, R; Ilie, M; Manda, G; Margină, DM; Neamţu, MC; Purdel, NC | 1 |
| Buhmann, CB; Carlsson, J; Ekstroem, M; Mortensen, EL; Nordentoft, M | 1 |
| Acion, L; Burin, DI; Jorge, RE; Robinson, RG | 1 |
| Akhondzadeh, S; Amidfar, M; Arbabi, M; Khiabany, M; Kohi, A; Mohammadinejad, P; Roohi Azizi, M; Salardini, E; Zarrindast, MR; Zeinoddini, A | 1 |
| Amidfar, M; Arbabi, M; Kim, YK; Quevedo, J; Réus, GZ | 1 |
| Christensen, C; Debes, NM; Kruuse, C; Leth, G; Martinussen, M; Pagsberg, AK | 1 |
| Jensen, TG; Kummen, I | 1 |
| Goecke, TW; Gründer, G; Paulzen, M; Schoretsanitis, G; Stickeler, E | 1 |
| Slawson, D | 1 |
| Frazee, E; Leung, JG; Loomis, EA; Philbrick, KL | 1 |
| Prasad, KP; Samaranayake, CN; Tharangani, PG | 1 |
| García-Sánchez, C; Gironell, A; Kulisevsky, J; Martínez-Corral, M; Pagonabarraga, J; Pascual-Sedano, B | 1 |
| Antonini, A | 1 |
| Doraiswamy, PM; Krishnan, KR; Kuchibhatla, M; Macfall, JR; Payne, ME; Sheline, YI; Taylor, WD | 1 |
| Barbour, K; Burg, M; Jaffe, A; Taylor, CB; Trockel, M | 1 |
| Terao, T | 1 |
| Alagna, A; Bramanti, P; Di Bella, P; Di Lorenzo, G; Digangi, G; Marino, S; Sessa, E | 1 |
| Vitiello, B | 1 |
| Bielecka-Grzela, S; Kacalak-Rzepka, A; Kiedrowicz, M; Maleszka, R; Mikulska, D; Ratajczak-Stefanska, V | 1 |
| Geerts, E; Gerlsma, C; van Os, T | 1 |
| Alkelai, A; Cooper-Kazaz, R; Glaser, B; Lerer, B; Medici, M; Peeters, RP; van der Deure, WM; Visser, TJ | 1 |
| Chen, H; Chen, VC; Chou, JY; Lin, NC | 1 |
| Ambrose, F; Ashman, TA; Cantor, JB; Egan, M; Engmann, C; Flanagan, S; Ginsberg, A; Gordon, WA; Greenwald, B; Spielman, L | 1 |
| Hassan, M; Marcus, SC; Olfson, M | 1 |
| Hautzinger, M; Hegerl, U; Helmreich, I; Henkel, V; Kohnen, R; Mergl, R; Tadić, A | 1 |
| Ahrold, TK; Meston, CM | 1 |
| Courtney, K | 1 |
| Azul, JB; Kuniyoshi, FH; Laterza, MC; Lotufo-Neto, F; Negrão, CE; Pullenayegum, EM; Rondon, MU; Scalco, AZ; Scalco, MZ; Trombetta, IC; Wajngarten, M | 1 |
| DeVeaugh-Geiss, AM; Gaynes, BN; Kroenke, K; Miller, WC; Sleath, B; West, SL | 1 |
| Cordes, JA; Edwards, A; Polk, MJ; Román, G; Royall, DR; Schillerstrom, JS; Velez, A | 1 |
| Dormuth, CR; Lee, JC; Mehta, J; Miller, M; Patrick, AR; Schneeweiss, S; Solomon, DH; Wang, PS | 1 |
| Baran, XY; Docherty, JP | 1 |
| Burgess, PM; Hollingworth, SA; Whiteford, HA | 1 |
| Filipcić, I; Jakovljević, M; Margetić, B; Simunović, I | 1 |
| Agius, M; Gardner, J; Liu, K; Zaman, R | 3 |
| Boricević Marsanić, V; Kusmić, E | 1 |
| Drye, LT; Frangakis, CE; Lyketsos, CG; Martin, BK; Meinert, CL; Mintzer, JE; Munro, CA; Porsteinsson, AP; Rabins, PV; Rosenberg, PB; Schneider, LS; Weintraub, D | 1 |
| Carney, RM; Freedland, KE; Harris, WS; Krone, RJ; Rich, MW; Rubin, EH; Stein, PK; Steinmeyer, BC | 1 |
| Malinina, EV; Zabozlaeva, IV | 1 |
| Feeny, NC; Keller, SM; Zoellner, LA | 1 |
| Espinosa, AG; Machado, RA; Montoto, AP | 1 |
| Allgaier, AK; Coyne, JC; Hautzinger, M; Hegerl, U; Henkel, V; Kohnen, R; Mergl, R; Möller, HJ | 1 |
| Allgaier, AK; Coyne, J; Hautzinger, M; Hegerl, U; Henkel, V; Kohnen, R; Kramer, D; Mergl, R | 1 |
| McGuinness, TM; Worley, J | 1 |
| Gordon, MS; Melvin, GA; Tonge, B | 1 |
| Hori, H; Ikenouchi-Sugita, A; Iwata, N; Kishi, T; Nakamura, J; Otani, K; Suzuki, A; Umene-Nakano, W; Yoshimura, R | 1 |
| Davidson, MB; Echeverry, D | 1 |
| Hellemann, G; London, ED; Shoptaw, S; Sugar, CA; Zorick, T | 1 |
| Kontsevoĭ, VA; Medvedev, AV | 1 |
| Chan, G; Chevarin, C; Du, X; Hannan, AJ; Lanfumey, L; Leang, L; Pang, TY; Renoir, T; Zajac, MS | 1 |
| Burke, HM; Epel, ES; Lerner, GK; Mellon, SH; Nelson, JC; Reus, VI; Rosser, R; Shelly, W; Wolf, J; Wolkowitz, OM | 1 |
| Brodaty, H | 1 |
| Baldwin, R; Ballard, C; Banerjee, S; Bentham, P; Burns, A; Dewey, M; Fox, C; Hellier, J; Holmes, C; Katona, C; Knapp, M; Lawton, C; Lindesay, J; Livingston, G; McCrae, N; Moniz-Cook, E; Murray, J; Nurock, S; O'Brien, J; Orrell, M; Poppe, M; Romeo, R; Thomas, A; Walwyn, R; Wilson, K | 1 |
| Dusetzina, SB; Ellis, AR; Farley, JF; Gaynes, BN; Hansen, RA; Miller, WC; Stürmer, T | 1 |
| Culang-Reinlieb, ME; Keilp, JG; Roose, SP; Sneed, JR | 1 |
| Calandra, C; Luca, M; Russo, RG | 1 |
| Allgaier, AK; Hautzinger, M; Hegerl, U; Helmreich, I; Henkel, V; Mergl, R; Tadić, A; Wagner, S | 1 |
| Chamielec, M; Gałecki, P; Talarowska, M; Zboralski, K | 1 |
| Hu, JB; Hu, SH; Huang, ML; Qi, HL; Wang, JW; Wang, SS; Wei, N; Xu, WJ; Xu, Y; Zhang, MM; Zhou, WH | 1 |
| Hsiung, GY; Jacova, C; Lee, PE; Sepehry, AA | 1 |
| Dahmen, N; Engel, A; Gerbaulet, M; Hiemke, C | 1 |
| Mandrioli, R; Mercolini, L; Raggi, MA; Saracino, MA | 1 |
| Chandrasekhar, CR; Math, SB; Narayanaswamy, JC; Rudhran, V; Shubrata, KS; Viswanath, B | 1 |
| Andrade, C | 1 |
| Klasik, A; Krysta, K; Krzystanek, M | 1 |
| Bondarenko, II; Kissin, MIa | 1 |
| Drye, LT; Frangakis, CE; Longmire, CF; Lyketsos, CG; Martin, BK; Meinert, CL; Mintzer, JE; Munro, CA; Porsteinsson, AP; Rabins, PV; Rosenberg, PB; Schneider, LS; Weintraub, D | 1 |
| Carmody, T; Hedayati, SS; Jain, N; Kurian, B; Rush, AJ; Sarode, R; Toto, RD; Trivedi, MH | 1 |
| Cox, GR; Hetrick, SE; McKenzie, JE; Merry, SN; Simmons, MB | 1 |
| Brandhorst, G; Müller, MJ; Paul, T; Preuß, C; Seeliger, S; Streit, F | 1 |
| Goriunov, AV; Lobacheva, MV | 1 |
| D'iakonov, AL; Lobanova, IV | 1 |
| Chaudron, LH | 1 |
| Adams, J; Graves, N; Solomon, D | 1 |
| Almeida, JR; Axelson, DA; Birmaher, B; Diler, RS; Ladouceur, CD; Pan, LA; Phillips, ML; Segreti, A | 1 |
| Abou-Saleh, M; Ashworth, L; Mottram, PG; Wilson, KC | 1 |
| Deuschle, M | 1 |
| Davis, SM; Gniwesch, L; Harrison, W; Howland, R; Klein, DN; Kocsis, JH; Rush, AJ; Schatzberg, A | 1 |
| Rupp, M; Schwarz, S; Zifko, UA | 1 |
| Gupta, S | 1 |
| Kruizinga, MJ; Ramaekers, JG; Riedel, WJ; Schmitt, JA; van Boxtel, MP; Vuurman, EF | 1 |
| Berney, P; Curtin, F; Kaufmann, C | 1 |
| Covey, LS; Glassman, AH; Rivelli, S; Stage, K; Stetner, F | 1 |
| Kline, NA; Matloff, JL; Stein, MB | 1 |
| Walker, L | 1 |
| Boyle, P; Correia, S; Krishnan, KR; Lavretsky, H; Malloy, P; Roose, S; Sackheim, H; Salloway, S; Schneider, L | 1 |
| Steinberg, DI | 1 |
| Frasure-Smith, N; Lespérance, F | 1 |
| DeVane, CL; Liston, HL; Markowitz, JS | 1 |
| Malt, UF | 1 |
| Heerdink, ER; Leufkens, HG; Meijer, WE; van Eijk, JT | 1 |
| Camacho, Y; Devanand, DP; Marston, K; Pelton, GH; Roose, SP; Sackeim, HA; Stern, Y | 1 |
| Cohen, LS; Hostetter, AL; Nemeroff, CB; Owens, MJ; Ritchie, JC; Sternberg, K; Stowe, ZN | 1 |
| Lo Sasso, AT; Sheffield, RE; Way, K; Young, CH | 1 |
| Caltagirone, C; Guida, G; Spalletta, G | 1 |
| Levenson, JL | 1 |
| Altshuler, LL; Haynes, D; Hendrick, V; Hwang, S; Lee, E; Stowe, ZN | 1 |
| Harrison, WM; Hirschfeld, RM; Keller, MB; Kornstein, SG; McCullough, JP; Russell, JM; Shea, MT | 1 |
| Persky, S; Reinus, JF | 1 |
| Abou-Saleh, MT; Ashworth, L; Mottram, PG; Wilson, KC | 1 |
| Leentjens, AF; Luijckx, GJ; Verhey, FR; Vreeling, FW | 1 |
| Arató, M; Austin, C; Lepola, U; Zhu, Y | 1 |
| Baker, AS; Brandt, J; DelCampo, L; Frangakis, C; Lyketsos, CG; Miles, Q; Munro, C; Rabins, PV; Sheppard, JM; Steele, CD; Steinberg, M | 1 |
| Johnson, B; Kennedy, JS; Mignot, E; Nishino, S; Ripley, B; Salomon, RM; Schmidt, D; Zeitzer, JM | 1 |
| Alpert, JE; Fava, M; Nierenberg, AA; Papakostas, GI; Petersen, T; Roffi, PA; Worthington, JJ | 1 |
| Agren, H; Bäuml, J; Behnke, K; Martin, S; Ravindran, AV; Søgaard, J; Vester-Blokland, ED | 1 |
| Bagby, RM; Grigoriadis, S; Kennedy, SH | 1 |
| Datto, CJ; DiFilippo, S; Katz, IR; Oslin, DW; Streim, JE; Ten Have, TR; Weintraub, D | 1 |
| El Sheshai, A; Fayek, M; Kingsbury, SJ; Rady, A; Simpson, GM | 1 |
| Kumar, S | 1 |
| Akerblad, AC; Bengtsson, F; Ekselius, L; von Knorring, L | 1 |
| Burt, T; Clary, CM; Coffey, DJ; Doraiswamy, PM; Jenkyn, LR; Krishnan, KR; Oxman, T | 1 |
| Burt, T; Cassidy, EL; Clary, CM; Doraiswamy, PM; Holland, PJ; Hornig, M; Mandel, FS; Salomon, RM; Sheikh, JI | 1 |
| Baca, E; Garcia-Garcia, M; Porras-Chavarino, A | 1 |
| Bisserbe, JC; Boyer, P; Caillard, V; Hotton, JM; Lépine, JP; Troy, S | 1 |
| Brown, EB; Joliat, MJ; Miner, CM | 1 |
| Eckert, G; Greco, T; Kroenke, K | 1 |
| Nelson, R | 1 |
| Reiner, WG; Scharko, AM | 1 |
| Cederberg, J; Knight, S; Melhus, H; Svenson, S | 1 |
| Martiny, K | 1 |
| Friedman, EH | 1 |
| Grieger, F; Leonard, J; Linden, M; Thiels, C | 1 |
| Allerup, P; Bech, P; Licht, RW; Qvitzau, S | 1 |
| Gastpar, M; Singer, A; Zeller, K | 1 |
| Glassman, AH; Harrison, DJ; O'Connor, CM | 1 |
| Bogetto, F; Calvarese, P; Faggiano, F; Marchiaro, L; Mathis, F; Rivoira, E; Rocca, P; Taricco, B | 1 |
| Clary, C; Endicott, J; Fayyad, R; Rapaport, MH | 1 |
| Phelps, JR | 1 |
| Asberg, M; Bartfai, A; Berggren, AL; Landtblom, AM; Lundmark, J; Mårtensson, B; Murray, V; Näsman, P; Olsson, JE; Samuelsson, M; Terént, A; Varelius, R; von Arbin, M | 1 |
| Abadie, P; Dollfus, S; Espiard, ML; Halbecq, I; Lecardeur, L | 1 |
| Bech, P; Dam, H; Lunde, M; Martiny, K; Undén, M | 1 |
| Fonareva, I; Hart, S; Merluzzi, N; Mohr, DC | 1 |
| Degner, D; Grohmann, R; Kropp, S; Porzig, J; Rüther, E | 1 |
| Lotrich, FE; Pollock, BG; Rosen, J | 1 |
| Akgöz, S; Akkaya, C; Eker, SS; Kirli, S; Sarandöl, A | 1 |
| Likasitwattanakul, S | 1 |
| Maximova, NM; Misionzhnik, EY; Uzbekov, MG; Vertogradova, OP | 1 |
| Johnson, BW; Salomon, RM; Schmidt, DE | 1 |
| Ahmed, A; Kinney, FC; Thornton, PL; Yaffe, MJ | 1 |
| Fan, A; Hong Ng, C; Klimidis, S; Kong Wai Ho, B; Naing, KO; Norman, TR; Schweitzer, I | 1 |
| Andrus, MR; Byrd, DC; Clark, DB | 1 |
| Ali, J; Devarajan, S; Dursun, SM | 1 |
| Aziz, S; Easteal, S; Ho, BK; Ng, CH; Schweitzer, I; Tan, S | 1 |
| Davidson, JR | 1 |
| Csoka, AB; Shipko, S | 1 |
| Casten, R; Pasternak, R; Rovner, BW | 1 |
| Altshuler, LL; Denicoff, KD; Frye, MA; Grunze, H; Keck, PE; Kitchen, CM; Kupka, RW; Leverich, GS; McElroy, S; Mintz, J; Nolen, WA; Post, RM; Suppes, T; Walden, J | 1 |
| Almeida, OP; Hankey, GJ; Waterreus, A | 1 |
| Baker, AS; Bay, RC; Lyketsos, CG; Mayer, LS; Politis, A; Rabins, PV; Steele, C; Steinberg, M | 1 |
| Bailly, D | 1 |
| Frangakis, CE; Katz, IR; Lyketsos, CG; Martin, BK; Meinert, CL; Mintzer, JE; Munro, CA; Niederehe, G; Porsteinsson, AP; Rabins, PV; Rosenberg, PB; Schneider, LS | 1 |
| Haro, JM; Peñarrubia, MT; Pinto-Meza, A; Serrano-Blanco, A; Suárez, D | 1 |
| Ros, LT | 1 |
| Harada, Y; Imaeda, T; Kohara, N | 1 |
| Armstrong, EP; Haim Erder, M; Skrepnek, GH; Ventura, D | 1 |
| Armstrong, EP; Haim Erder, M; Skrepnek, GH | 1 |
| Trenina, EA; Volchegorskii, IA | 1 |
| Abdi, EA; Beale, PJ; Carter, C; Dhillon, H; Glasgow, A; Goldstein, D; Heritier, S; Hickie, IB; Jefford, M; Nowak, AK; O'Connell, R; Simes, RJ; Stockler, MR; Turner, J; Wilcken, NR; Wyld, D | 1 |
| Fisch, M | 1 |
| Ghanizadeh, A | 1 |
| Hetrick, S; McKenzie, J; Merry, S; Proctor, M; Sindahl, P | 1 |
| Drago, F; Leggio, GM; Micale, V | 1 |
| Caldera, P; Siri, I; Torta, R | 1 |
| Burg, MM; Cornell, CE; Cowan, MJ; Czajkowski, SM; Freedland, KE; Powell, LH; Saab, PG; Youngblood, ME | 1 |
| Devanand, DP; Harper, OL; Pelton, GH; Roose, SP; Sackeim, HA; Scarmeas, N; Tabert, MH | 1 |
| Beekman, AT; Comijs, HC; Deeg, DJ; Sonnenberg, CM; van Tilburg, W | 1 |
| Mizrahi, R; Power, BD; Starkstein, SE | 1 |
| Dougherty, D; Hilal, R; Nandagopal, VS; Nesbitt, L; Sallee, FR; Sethuraman, G | 1 |
| Kent, LS; Laidlaw, JD | 1 |
| Kelly, JP; Leonard, BE | 1 |
| Rothschild, AJ | 1 |
| Gorman, JM; Greenberg, HE; Klein, DF; Papp, LA; Rifkin, A; Scharf, SM; Weiss, JR | 1 |
| Fedoroff, JP | 1 |
| Baumann, P; Rochat, B | 1 |
| Preskorn, SH | 2 |
| Finley, PR | 1 |
| Resch, DS; Thornton, SL | 1 |
| Carson, W; Jackson, C; Markowitz, J; Mintzer, J | 1 |
| Goldberg, JF; Kocsis, JH; Sacks, MH | 1 |
| Bennie, EH; Martindale, JJ; Mullin, JM | 1 |
| Altshuler, LL; Burt, VK; Hendrick, V; McMullen, M | 1 |
| Biro, FM; Harel, Z; Tedford, WL | 1 |
| Brown, WA; Harrison, W | 2 |
| Bradford, JM; Gratzer, TG | 1 |
| Hoaken, PC | 1 |
| Kafka, MP | 1 |
| Gitlin, MJ | 1 |
| Franko, T; Mendelson, WB | 1 |
| Makela, EH; Sullivan, P; Taylor, M | 1 |
| Graber, MA; Hoehns, TB; Perry, PJ | 1 |
| Eick, TJ; Kofoed, L | 1 |
| Rabkin, JG; Rabkin, R; Wagner, G | 1 |
| Altshuler, LL; Ames, D; Pierre, JM; Wirshing, WC | 1 |
| Alpert, JE; Fava, M; Maddocks, A; Rosenbaum, JF | 1 |
| Preskorn, S | 1 |
| Thompson, C | 3 |
| Turner, R | 1 |
| Casey, DE | 1 |
| Domino, EF; Holmes, RD; Lee, A; Markel, H | 1 |
| Mazmanian, D; Sharma, V | 1 |
| Doogan, DP; Langdon, CJ | 1 |
| Hall, MJ | 1 |
| McCall, WV | 1 |
| Kline, MD; Koppes, S | 1 |
| Bronzo, MR; Stahl, SM | 1 |
| Gales, BJ; Gales, MA | 1 |
| Brown, SA; Dow, BM; Kline, NA; Matloff, JL | 1 |
| Borison, R; Doshi, D | 1 |
| Ghaziuddin, M | 1 |
| Asnis, G; Barros, J | 1 |
| Lydiard, RB; Robert, JM | 1 |
| Overstreet, DH; Pucilowski, O | 1 |
| Calabrese, JR; Rapport, DJ | 1 |
| Settle, EC | 1 |
| Dinan, TG | 1 |
| Aguglia, E; Bolino, F; Casacchia, M; Cassano, GB; Faravelli, C; Ferrari, G; Giordano, P; Pancheri, P; Ravizza, L; Trabucchi, M | 1 |
| Ellison, JM; Stanziani, P | 1 |
| Bakish, D; Joffe, RT | 1 |
| Rapport, D; Shihabuddin, L | 1 |
| Anton, RF; Cunningham, T; Lydiard, RB | 1 |
| Freimer, M; Gupta, S; Popli, A | 1 |
| LaPorta, LD | 1 |
| Crews, JR; Lipper, S; Potts, NL; Schreiber, J | 1 |
| Kupfer, DJ | 1 |
| Klee, B; Kronig, MH | 1 |
| Joostens, P; Van Houdenhove, B | 1 |
| Dickey, TO; el-Khatib, HE | 1 |
| Freeman, EW; Rickels, K; Sondheimer, SJ; Wittmaack, FM | 1 |
| Hauser, RA; Zesiewicz, TA | 1 |
| Leiter, FL; Nierenberg, AA; Sanders, KM; Stern, TA | 1 |
| Heimann, SW; March, JS | 1 |
| Abuzzahab, FS; Amin, M; Claghorn, JL; Dubé, S; Fabre, LF; Mendels, J; Petrie, WM; Small, JG | 1 |
| Flint, AJ | 1 |
| McConnell, JG; Taylor, IC | 1 |
| Cole, JO; Kando, JC; Tohen, M; Weiss, MK; Zarate, CA | 1 |
| Brewerton, TD; Cochrane, CE; Keller, SG; Markowitz, JS | 1 |
| Engel, NL; Rubenstein, EB | 1 |
| Calhoun, DD; Calhoun, JW | 1 |
| Asihene, R; Balser, S; Barker, M; Goldstein, L; Lautenbach, D; McCoy, M; Segall, F | 1 |
| Joffe, RT; Levitt, AJ; Sokolov, ST; Young, LT | 1 |
| Brill, P; McConnell, H; Nussbaum, P; Scott, TF | 1 |
| Gilman, D; Hayden, CT; Kalivas, J; Kalivas, L | 1 |
| Bhatara, VS; Freeman, JW; Gupta, S | 1 |
| Berman, R; Charney, DS; Delgado, PL; Heninger, GR; Krystal, JH; Miller, HL; Salomon, RM | 1 |
| Newhouse, PA | 1 |
| Byerly, MJ; Christensen, RC; Evans, OL | 1 |
| Lane, RM | 1 |
| Leung, M; Remick, R | 1 |
| Roy, A | 1 |
| Rosenstock, HA | 1 |
| Bourgeois, JA | 1 |
| Shopper, M | 1 |
| Kat, H | 1 |
| Fenyo, A; Forder, J; Kavanagh, S | 1 |
| Davidson, J; Fava, M; Halbreich, U; Harrison, W; Kocsis, JH; Koran, L; Rosenbaum, J; Thase, ME | 1 |
| Carek, DJ | 1 |
| Friedman, T; Ratan, DA | 1 |
| Fava, GA; Grandi, S | 1 |
| Alberts, VA; Catalano, G; Catalano, MC; Kanfer, SN | 1 |
| Byerly, MJ; Christensen, RC; McElroy, RA | 1 |
| Lesaca, TG | 1 |
| Reynolds, CF | 1 |
| Cowen, PJ; McTavish, SF; Williamson, DJ | 1 |
| Leo, RJ | 1 |
| de Vet, HC; Hartmans, M; Honig, A; Menting, JE; Rozendaal, N; van Praag, HM; Verhey, FR | 1 |
| Berndt, ER; Finkelstein, SN; Greenberg, PE; Keller, MB; Parsley, RA; Russell, JM | 1 |
| Brown, C; Freeman, E; Halbreich, U; Pearlstein, T; Yonkers, KA | 1 |
| Grimes, JB; Labbate, LA | 1 |
| Franchini, L; Gasperini, M; Perez, J; Smeraldi, E; Zanardi, R | 2 |
| Chavez, M; Contreras, SA; Malek-Ahmadi, P | 1 |
| Alderman, CP; Lee, PC | 1 |
| Abel, L; Buchsbaum, MS; Hackett, E; Reynolds, C; Siegel, BV; Trenary, M; Wu, J | 1 |
| Lock, J | 1 |
| DeQuardo, JR; Lewis, CF; Tandon, R | 1 |
| Labbate, LA; Oleshansky, MA | 1 |
| Byerly, MJ; Christensen, RC | 1 |
| Olivera, AO | 1 |
| Berti, C; Burnett, F; Cooney, J; Dash, A; Dinan, TG; Lavelle, E; Scott, L; Thakore, J | 1 |
| Apter, JT; Birkett, MA; Blomgren, SL; Tepner, RG; Thase, ME | 1 |
| Rifkin, A | 1 |
| Reynolds, RD | 1 |
| Bouman, WP; Johnson, H; Jones, RG; Trescoli-Serrano, C | 1 |
| Charness, WE; Ferrando, SJ; Goldman, JD | 1 |
| Foglia, JP; Mammen, OK; Perel, JM; Rudolph, G; Wheeler, SB | 1 |
| Yonkers, KA | 1 |
| Fava, M; Nierenberg, AA; Pearlstein, T; Quitkin, FM; Rosenbaum, JF; Stone, A; Zisook, S | 1 |
| Klein, HM; Raison, CL | 1 |
| Agosti, V; Stewart, JW | 1 |
| Baldessarini, RJ; Bodkin, JA; Gardner, DM; Lasser, RA; Wines, JD | 1 |
| de Koning, FH; Egberts, AC; Lenderink, AW; Leufkens, HG | 1 |
| Byrne, S; Rothschild, AJ | 1 |
| Darby, AL; Lesser, IM; Miller, BL; Swartz, JR | 1 |
| Burke, WJ; Dewan, V; Folks, DG; Nadolny, GC; Roccaforte, WH; Wengel, SP | 1 |
| Nunes, EV; Schechter, DS | 1 |
| Buki, VM; Goldberg, RB; Goodnick, PJ; Henry, JH; Kumar, A | 1 |
| Bundren, JC; Warnock, JK | 1 |
| Christian, K; Friedman, LM; McConville, BJ; Minnery, KL; Sorter, MT; West, SA | 1 |
| Findling, RL | 1 |
| Guilé, JM | 1 |
| Ely, T; Kilts, CD; Landry, JC; Llewellyn, A; Nemeroff, CB; Owens, MJ; Stowe, ZN | 1 |
| Bagby, RM; Dickens, SE; Joffe, R; Kennedy, SH; Levitt, A; Minifie, CE; Schuller, DR | 1 |
| Sprenger, D | 1 |
| Jennings, K; Mammen, O; Popper, S; Shear, K | 1 |
| Mulsant, BH; Pollock, BG; Reynolds, CF; Rosen, J; Solai, LK; Sweet, RA; Yu, K | 1 |
| Moss, JH | 1 |
| Gregor, KJ; James, SP; Way, K; Young, CH | 1 |
| Pinkofsky, HB; Reeves, RR; Stone, KD | 1 |
| Harrison, WM; Hertzman, M; Lydiard, RB; Stahl, SM | 1 |
| Ascher, JA; Hughes, AR; Johnston, JA; Kavoussi, RJ; Segraves, RT | 1 |
| Cohen, LS | 1 |
| Cohen, CI; Trappler, B | 1 |
| Buesching, DP; Croghan, TW; Crown, WH; Heiligenstein, JH; Hylan, TR; Melfi, CA; Meneades, L | 2 |
| Fawcett, J; Mitchell, S; Zajecka, J | 1 |
| Purdon, SE; Snaterse, M | 1 |
| Biondi, M; Bonaccorso, S; DeClerck, L; Janca, A; Libbrecht, I; Lin, AH; Maes, M; Scharpé, S; Van Hunsel, F; Verkerk, R | 1 |
| Benedek, DM; Howard, RS; Hurt, PH; Young, SA | 1 |
| Armstrong, A; Bullis, J; Engel, AL; Engel, CC; Walker, EA | 1 |
| Arranz, FJ; Ros, S | 1 |
| Eberhard, G; Ekselius, L; von Knorring, L | 1 |
| Alderman, J; Chung, M; Johnston, HF; Wolkow, R | 1 |
| Connor, KM; Davidson, JR | 1 |
| Blumer, J; Perel, JM; Wisner, KL | 1 |
| Mazo, GE; Razorenov, GI; Razorenova, TS; Vovin, RIa | 1 |
| Andrews, W; Barrett, E; Parker, G | 1 |
| Bouwer, C; Stein, DJ | 1 |
| Hobson, P; Meara, J | 1 |
| Benazzi, F | 1 |
| Ruiz, P; Small, DR; Varner, RV | 1 |
| Ascroft, RC; Fava, M; Hoog, SL; Krebs, WB; Rosenbaum, JF | 1 |
| Markowitz, JS | 1 |
| Beach, K; Dougherty, D; Hilal, R; Nesbitt, L; Sallee, FR | 1 |
| Keck, PE; McElroy, SL; Soutullo, CA | 1 |
| Bundren, JC; Morris, DW; Warnock, JK | 1 |
| Roose, SP; Suthers, KM | 1 |
| Lambert, MT; Petty, F; Trutia, C | 1 |
| Diaz, S; Howard, M; Jain, N; Pearlstein, T; Zlotnick, C | 1 |
| Caliskan, M; Kirli, S | 1 |
| Asnis, G; Efremova, I | 1 |
| Longhurst, JG; Weiss, E | 1 |
| Ekselius, L; von Knorring, L | 1 |
| Rand, EH | 1 |
| Fawcett, JA; Gelenberg, AJ; Harrison, W; Hirschfeld, R; Keller, MB; Klein, D; Kocsis, JH; Koran, L; Kornstein, S; LaVange, L; McCullough, JP; Rush, AJ; Russell, J; Schatzberg, A; Thase, ME | 1 |
| Arató, M; Bauer, H; Gallinat, J; Hegerl, U; Janka, Z; Möller, HJ; Pflug, B | 1 |
| Ruiz, P | 1 |
| Levsky, ME; Schwartz, JB | 1 |
| Fawcett, JA; Gelenberg, AJ; Harrison, WM; Hirschfeld, RM; Keller, MB; Klein, DN; Kocsis, JH; Koran, LM; Markowitz, JC; McCullough, JP; Miceli, RJ; Rush, AJ; Schatzberg, AF; Thase, ME | 1 |
| Davis, SM; Fawcett, JA; Gelenberg, AJ; Harrison, WM; Hirschfeld, RM; Keller, MB; Klein, DN; Kocsis, JH; Koran, LM; Kornstein, SG; Markowitz, JC; McCullough, JP; Rush, AJ; Russell, JM; Thase, ME | 1 |
| Davis, SM; Harrison, WM; Keitner, GI; Keller, MB; Klein, DN; Kornstein, SG; Markowitz, JC; Miller, IW; Rush, AJ; Schatzberg, AF; Schlager, DS; Thase, ME | 1 |
| Behar, D; Schaller, JL | 1 |
| Connolly, MA; Delgado, PL; Fawcett, J; Friedman, RA; Harrison, WM; Hirschfeld, RM; Howland, RH; Koran, LM; Miceli, RJ; Miller, IW; Russell, JM; Thase, ME | 1 |
| Schneck, C | 1 |
| Aromin, R; Hellerstein, DJ; Kelton, GM; Londono, JH; Muran, JC; Postolache, TT; Rosenthal, RN | 1 |
| Voris, JC | 1 |
| Davis, R; Wilde, MI | 1 |
| Bisserbe, JC; Boyer, P; Danion, JM; Hotton, JM; Troy, S | 1 |
| Clary, CM; Finkel, SI; Richter, EM | 1 |
| Altshuler, L; Cantrell, R; Gillespie, W | 1 |
| Bakke, O; Loeb, M; Madsbu, HP; Malt, UF; Robak, OH | 1 |
| Ambrosini, PJ; Biederman, J; Elia, J; Geller, D; Glick, I; Hebeler, JR; Lock, J; Rabinovich, H; Tan, C; Wagner, KD | 1 |
| Karim, A | 1 |
| Phillips, KA; Rothschild, AJ | 1 |
| Baldessarini, RJ; Viguera, AC | 1 |
| Comesaña Díaz, E; Klimovsky, S; Lyketsos, CG; Paz, J; Schapira, M; Taragano, F | 1 |
| Carleborg, L; Hägg, S; Ohman, R; Spigset, O | 1 |
| Galin, RS; Robison, LM; Sclar, DA; Skaer, TL | 1 |
| Flament, MF; Lane, RM; Ying, Z; Zhu, R | 1 |
| Freeman, EW; Polansky, M; Rickels, K; Sondheimer, SJ | 1 |
| Berndt, ER; Colucci, S; Grudzinski, AN; Miceli, R; Russell, JM | 1 |
| Chibnall, JT; Desai, A | 1 |
| de Moore, GM; Ferrando, SJ; Rabkin, JG; Rabkin, R | 1 |
| Black, DW; Chapman, D; Clary, C; Greist, JH; Harrison, W; Hoehn-Saric, R; Lydiard, B; McElroy, S; Ninan, P; Stahl, S; Zajecka, J | 1 |
| Cohen, CI; Gomberg, D; Kennedy, G; Magai, C | 1 |
| Deisenhammer, EA; Trawöger, R | 1 |
| Behnke, K; Christiansen, PE; Goodwin, DP; Lane, R; Latimer, P; Nielsen, B; Ravindran, AV; Reesal, RT; Søgaard, J | 1 |
| Amsterdam, J; Apter, J; Fava, M; Londborg, P; Michelson, D; Pagh, L; Tamura, R | 1 |
| Mulsant, BH; Pollock, BG; Rosen, J | 1 |
| Miser, WF | 1 |
| Behnke, K; Mehtonen, OP; Roponen, P; Søgaard, J | 1 |
| Barbenel, DM; Bench, CJ; O'Shea, D; Yusufi, B | 1 |
| Voloshin, VM | 1 |
| Bagnères, D; Dadoun, F; Darmon, P; Demoux, AL; Frances, Y; Raharimanana, RN; Tonolli, I; Velut, JG | 1 |
| Ascher, JA; Batey, SR; Donahue, R; Hughes, AR; Johnston, JA; Kavoussi, R; Segraves, RT | 1 |
| Cole, SM; Helstad, CP; Henk, HJ; Katzelnick, DJ; Kobak, KA; Lin, EH; Manning, WG; Pearson, SD; Simon, GE; Taylor, LH | 1 |
| Alpert, M; Batzar, E; Bondareff, W; Clary, CM; Friedhoff, AJ; Richter, EM | 1 |
| Franchini, L; Gasperini, M; Smeraldi, E; Zanardi, R | 1 |
| Cooper, T; DiFilippo, SD; Katz, IR; Oslin, DW; Smith, BD; Streim, JE; Ten Have, TR | 1 |
| Dunn, NR; Freemantle, SN; Mackay, FR; Mann, RD; Martin, RM; Pearce, GL | 1 |
| Bacchiochi, JR; Bagby, RM; Dickens, SE; Eisfeld, BS; Kennedy, SH | 1 |
| Baldwin, D; Bourgeois, M; Healy, D; Hirschfeld, RM; Humble, M; Kasper, S; Keller, MB; Möller, HJ; Montenegro, R; Montgomery, SA; Schatzberg, AF; Versiani, M | 1 |
| Berndt, ER; Finkelstein, SN; Gelenberg, AJ; Keller, MB; Koran, LM; Kornstein, SG; Miller, IM; Thase, ME; Trapp, GA | 1 |
| Chitwood, WS; Markovitz, JH; May, RS; Shuster, JL; Tolbert, LC | 1 |
| Fava, M; Hoog, SL; Kopp, JB; Nilsson, ME; Rosenbaum, JF; Tepner, RG | 1 |
| Hamilton, SP; Janal, M; Nunes, EV; Weber, L | 1 |
| Khan, A; Preskorn, SH; Shad, MU | 1 |
| Davis, SM; Gelenberg, AJ; Harrison, WM; Keitner, GI; Keller, MB; Kornstein, SG; McCullough, JP; Schatzberg, AF; Thase, ME; Yonkers, KA | 1 |
| Baier, D; Kohnen, R; Philipp, M; Tiller, JW | 1 |
| Bongiorno, F; Franchini, L; Rossini, D; Smeraldi, E; Spagnolo, C; Zanardi, R | 1 |
| Batzar, ED; Clary, CM; Doraiswamy, PM; Krishnan, KR; Newhouse, PA; Richter, EM | 1 |
| Freeman, EW; Garcia-Espagna, B; Polansky, M; Sondheimer, SJ | 1 |
| Blashko, C; Goger, J; Kosolowski, J; Lane, RM; Lépine, JP; Moles, MF; Probst, C; Scharfetter, B | 1 |
| Bengtsson, F; Ekselius, L; von Knorring, L | 1 |
| Fann, JR; Katon, WJ; Uomoto, JM | 1 |
| Baker, AS; Brandt, J; Kopunek, S; Lyketsos, CG; Rabins, PV; Sheppard, JM; Steele, CD; Steinberg, M | 1 |
| Cooksley, WG; Lawford, BR; Macdonald, GA; Schramm, TM | 1 |
| Louie, J; Moeller, JR; Nobler, MS; Prohovnik, I; Roose, SP; Sackeim, HA; Van Heertum, RL | 1 |
| Stahl, SM | 1 |
| Woods, SW | 1 |
| Cassano, GB; Guelfi, JD; Lane, RM; Ravindran, AV | 1 |
| Fava, M; Hoog, SL; Judge, R; Koke, SC; Nilsson, ME | 1 |
| Sheridan, MJ; Wise, TN | 1 |
| Clary, CM; Fayyad, R; Londborg, P; Sheikh, JI | 1 |
| Harkin, A; Kelly, JP; Leonard, BE; Nally, R | 1 |
| Marsland, TW; Newton, W | 1 |
| Caputo, RM; Stern, S; Votolato, NA | 1 |
| Fitzgerald, F; Glod, CA; Lynch, A | 1 |
| Bhanji, NH | 1 |
| Altshuler, LL; Calcagno, JL; Frye, MA; Gitlin, MJ; Hwang, S; Rasgon, NL; Suri, RA; Zuckerbrow-Miller, J | 1 |
| Ferguson, JM | 1 |
| Borian, F; Ferguson, JM; Hartford, JT; Ieni, J; Jody, D; McQuade, RD; Shrivastava, RK; Stahl, SM | 1 |
| Aberg-Wistedt, A; Khoury, AE; Stain-Malmgren, R; Tham, A | 1 |
| Kropp, S; Schlimme, J; Schneider, U | 1 |
| Cnaan, A; Kranzler, HR; Luck, G; Pettinati, HM; Rukstalis, MR; Volpicelli, JR | 1 |
| Clary, CM; Doraiswamy, PM; Krishnan, KR | 1 |
| Mendelson, SD | 1 |
| Panzarino, PJ; Xuan, J | 1 |
| Carrazana, EJ; Rey, GJ; Rey, JA; Rivas-Vazquez, RA | 1 |
| Cloutier, P; Milin, R; Nixon, MK; Simeon, JG; Spenst, W | 1 |
| Gerek, S; Härtter, S; Hiemke, C; Müller, M; Weigmann, H; Zeisig, A | 1 |
| Ramasubbu, R | 1 |
| McGrath, PJ; Quitkin, FM; Stewart, JW | 1 |
| Kashnikova, AA; Kim, LV; Koren', EV; Tatarova, IN; Voloshina, VM | 1 |
| Nemeroff, CB | 1 |
| Cherian, F; Fallen, EL; Kamath, MV; Malcolm, V; McFarlane, A; Norman, G | 1 |
| Nelson, JC | 1 |
| Amore, M; Jori, MC | 1 |
| Dolor, R; Eckert, GJ; Gilsenan, A; Hays, R; Kroenke, K; Stang, P; Swindle, R; Weinberger, M; West, SL; Zhou, XH | 1 |
| Boskailo, E; Durić-Bijedić, Z; Lewis, J; Pavković, I; Smajkić, A; Weine, S | 1 |
| Davis, MW; Fisher, AA | 1 |
| Bauer, MS; Glick, HA; Onesirosan, P; Polsky, D | 1 |
| Frank, E; Kupfer, DJ | 1 |
| Bauer, L; Khin, NA; Oakley, F; Parks, R; Sunderland, T | 1 |
| Ayache, DC; Junior, RF | 1 |
| Raphael, K; Tokeshi, J | 1 |
| Cronholm, P; Straton, JB | 1 |
| Jakovljević, M; Korsić, M; Mihaljević-Peles, A; Mück-Seler, D; Pivac, N; Sagud, M | 1 |
| Clegg, F; Hassan, N; Pierce, K; Turner-Stokes, L | 1 |
| Brenner, R; Madhusoodanan, S; Pawlowska, M | 1 |
| Bellavance, F; Haiek, LN; McCusker, J; Meterissian, GB; van Gurp, G | 1 |
| Bergmann, K; Bindman, J; Jennings, AL; Phillips, J; Seth, R | 1 |
| Grimsley, SR; Jann, MW | 1 |
| Mendels, J | 1 |
| Berman, H; Salzman, C; Sapers, BL | 1 |
| Bullock, T; Fineberg, NA; Montgomery, DB; Montgomery, SA | 1 |
| de Jongh, PM; Keppel Hesselink, JM | 1 |
| Montgomery, S | 1 |
| Burke, M; Preskorn, SH | 1 |
| DeVane, CL | 1 |
| Johnson, AM; Tulloch, IF | 1 |
| Goodman, WK; McDougle, CJ; Price, LH | 1 |
| Caillard, V; Doogan, DP | 2 |
| Warrington, SJ | 1 |
| Lapierre, YD | 1 |
| Burnside, R; Doogan, DP; Montgomery, SA | 1 |
| Doogan, DP | 1 |
| Karagianis, JL | 1 |
| Rickels, K; Schweizer, E | 1 |
| Chouinard, G; Cohn, CK; Cole, JO; Itil, TM; LaPierre, YD; Masco, HL; Mendels, J; Reimherr, FW | 1 |
| Claghorn, JL; Cohn, CK; Cohn, JB; Dessain, EC; Fabre, LF; Itil, TM; Lautin, A; Mendels, J; Shrivastava, R | 1 |
| Guy, S; Silke, B | 1 |
| Heym, J; Koe, BK | 1 |
| Mattila, M; Mattila, MJ; Saarialho-Kere, U | 1 |
| Byerley, WF; Lebegue, BJ; Reimherr, FW; Ward, MF; Wender, PH | 1 |
| Knott, VJ; Lapierre, YD | 1 |
| Lautin, A; Novatt, A; Peselow, ED; Rohrs, C; Rotrosen, J; Siekierski, J; Wolkin, A | 1 |
| Beauclair, L; Chouinard, G; Goldbloom, D; Laporta, M | 1 |
63 review(s) available for sertraline and Depression, Endogenous
| Article | Year |
|---|---|
[Recent approaches to the diagnosis and therapy of monopolar depression].
Topics: Depression; Depressive Disorder; Humans; Psychometrics; Selective Serotonin Reuptake Inhibitors; Sertraline | 2023 |
Minor and subthreshold depressive disorders in Alzheimer's disease: A systematic review and meta-analysis of prevalence studies.
Topics: Alzheimer Disease; Depression; Depressive Disorder; Humans; Randomized Controlled Trials as Topic; Sertraline | 2020 |
Platelet function defects and sertraline-induced bleeding: a case report.
Topics: Aged; Blood Platelets; Depressive Disorder; Diagnosis, Differential; Epistaxis; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline | 2020 |
Exploring the utility of RDoC in differentiating effectiveness amongst antidepressants: A systematic review using proposed psychometrics as the unit of analysis for the Negative Valence Systems domain.
Topics: Algorithms; Antidepressive Agents; Citalopram; Clinical Trials as Topic; Depressive Disorder; Desvenlafaxine Succinate; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Psychometrics; Sertraline; Treatment Outcome | 2020 |
Incidence of early anxiety aggravation in trials of selective serotonin reuptake inhibitors in depression.
Topics: Adult; Akathisia, Drug-Induced; Anxiety; Citalopram; Clinical Trials as Topic; Depressive Disorder; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Paroxetine; Psychomotor Agitation; Selective Serotonin Reuptake Inhibitors; Sertraline | 2017 |
Advances in Pharmacotherapy of Late-Life Depression.
Topics: Antidepressive Agents; Aripiprazole; Depression; Depressive Disorder; Drug Resistance; Duloxetine Hydrochloride; Humans; Paroxetine; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Vortioxetine | 2018 |
Comparative cardiovascular safety of selective serotonin reuptake inhibitors (SSRIs) among Chinese senile depression patients: A network meta-analysis of randomized controlled trials.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Asian People; Cardiovascular Diseases; China; Citalopram; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 2019 |
The influence of sertraline on depressive disorder after traumatic brain injury: A meta-analysis of randomized controlled studies.
Topics: Adult; Aged; Brain Injuries, Traumatic; Depressive Disorder; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2019 |
A systematic review of Chinese randomized clinical trials of SSRI treatment of depression.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; China; Citalopram; Depressive Disorder; Double-Blind Method; Fluoxetine; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 2014 |
Sertraline and breastfeeding: review and meta-analysis.
Topics: Antidepressive Agents; Breast Feeding; Depressive Disorder; Female; Humans; Infant; Lactation; Milk, Human; Selective Serotonin Reuptake Inhibitors; Sertraline | 2015 |
Forced swim test: What about females?
Topics: Animals; Antidepressive Agents; Depressive Disorder; Disease Models, Animal; Dose-Response Relationship, Drug; Estrogens; Estrous Cycle; Female; Male; Motor Activity; Progesterone; Rats, Wistar; Sertraline; Sex Characteristics; Swimming; Testosterone | 2015 |
Rowell's syndrome in the course of treatment with sodium valproate: a case report and review of the literature data.
Topics: Antipsychotic Agents; Benzodiazepines; Depressive Disorder; Drug Therapy, Combination; Erythema Multiforme; Female; Humans; Lupus Erythematosus, Cutaneous; Middle Aged; Olanzapine; Pericarditis; Sertraline; Syndrome; Treatment Outcome; Valproic Acid | 2009 |
Use of SSRIs in pregnancy: neonatal implications.
Topics: Adult; Decision Making; Depressive Disorder; Female; Humans; Pregnancy; Pregnancy Complications; Pregnancy Trimesters; Prenatal Exposure Delayed Effects; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline | 2009 |
[Vascular depressions].
Topics: Adaptation, Psychological; Affective Symptoms; Asymptomatic Diseases; Brain; Catastrophization; Cerebral Arteries; Cerebrovascular Disorders; Depressive Disorder; Diagnosis, Differential; Humans; Prognosis; Psychotherapy; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline | 2011 |
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Dementia; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Mental Disorders; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Sertraline | 2011 |
Repetitive transcranial magnetic stimulation-induced seizure of a patient with adolescent-onset depression: a case report and literature review.
Topics: Adolescent; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder; Female; Humans; Seizures; Sertraline; Transcranial Magnetic Stimulation | 2011 |
Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions.
Topics: Benzofurans; Citalopram; Depressive Disorder; Drug Monitoring; Fluoxetine; Fluvoxamine; Humans; Indoles; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Vilazodone Hydrochloride | 2012 |
Newer generation antidepressants for depressive disorders in children and adolescents.
Topics: Adolescent; Antidepressive Agents; Child; Citalopram; Depressive Disorder; Fluoxetine; Humans; Induction Chemotherapy; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide | 2012 |
Complex challenges in treating depression during pregnancy.
Topics: Abnormalities, Drug-Induced; Adult; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Psychotherapy; Recurrence; Risk Assessment; Sertraline | 2013 |
Clinical pharmacokinetics of sertraline.
Topics: Aged; Aging; Biological Availability; Biotransformation; Child; Depressive Disorder; Drug Interactions; Drug Overdose; Female; Humans; Kidney Diseases; Lactation; Liver Diseases; Pregnancy; Protein Binding; Selective Serotonin Reuptake Inhibitors; Sertraline; Tissue Distribution | 2002 |
Sertraline hepatotoxicity: a case report and review of the literature on selective serotonin reuptake inhibitor hepatotoxicity.
Topics: Adult; Biopsy, Needle; Depressive Disorder; Female; Follow-Up Studies; Hepatitis; Humans; Immunohistochemistry; Liver; Liver Function Tests; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index | 2003 |
Pharmacologic treatment of acute and chronic stress following trauma: 2006.
Topics: Algorithms; Anxiety Disorders; Comorbidity; Depressive Disorder; Disasters; Drug Administration Schedule; Humans; Internet; Paroxetine; Psychotropic Drugs; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Stress Disorders, Traumatic, Acute; Survivors; Treatment Outcome | 2006 |
[Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].
Topics: Adolescent; Adult; Age Factors; Antidepressive Agents, Second-Generation; Case-Control Studies; Child, Preschool; Citalopram; Confidence Intervals; Depressive Disorder; Family Practice; Female; Fluoxetine; Fluvoxamine; History, Medieval; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Placebos; Psychotherapy; Randomized Controlled Trials as Topic; Risk; Safety; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sertraline; Suicide; Suicide, Attempted | 2006 |
[Pharmacological, pharmacokinetic, and clinical profile of sertraline hydrochloride (J ZOLOFT)].
Topics: Animals; Antidepressive Agents; Depressive Disorder; Humans; Panic Disorder; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Tablets | 2006 |
Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
Topics: Adolescent; Antidepressive Agents; Child; Citalopram; Depressive Disorder; Fluoxetine; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide | 2007 |
Antidepressant therapy in post-stroke depression.
Topics: Antidepressive Agents; Citalopram; Controlled Clinical Trials as Topic; Depressive Disorder; Humans; Nortriptyline; Prognosis; Sertraline; Stroke; Treatment Outcome | 2008 |
Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror.
Topics: 1-Naphthylamine; Animals; Citalopram; Cytochrome P-450 Enzyme System; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Stereoisomerism | 1995 |
Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
Topics: 1-Naphthylamine; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Design; Drug Tolerance; Drugs, Investigational; Fluoxetine; Humans; Imipramine; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride | 1995 |
Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions.
Topics: 1-Naphthylamine; Alcoholism; Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Sertraline-phenelzine drug interaction: a serotonin syndrome reaction.
Topics: 1-Naphthylamine; Blood Pressure; Depressive Disorder; Drug Interactions; Female; Humans; Middle Aged; Phenelzine; Respiration; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Syndrome | 1994 |
Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline.
Topics: 1-Naphthylamine; Depressive Disorder; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Half-Life; Humans; Metabolic Clearance Rate; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Striking a balance between safety and efficacy: experience with the SSRI sertraline.
Topics: 1-Naphthylamine; Adult; Brain; Cross-Sectional Studies; Depressive Disorder; Humans; Incidence; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States | 1994 |
Management of recurrent depression.
Topics: 1-Naphthylamine; Antidepressive Agents; Chronic Disease; Combined Modality Therapy; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Imipramine; Paroxetine; Psychotherapy; Recurrence; Sertraline | 1993 |
Discontinuation reactions following sertraline.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Attention; Depressive Disorder; Fatigue; Female; Gait; Headache; Humans; Irritable Mood; Male; Sertraline; Substance Withdrawal Syndrome; Tinnitus; Vertigo | 1995 |
Does intolerance or lack of response with fluoxetine predict the same will happen with sertraline?
Topics: 1-Naphthylamine; Adolescent; Adult; Bipolar Disorder; Depressive Disorder; Drug Tolerance; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Use of serotonin selective reuptake inhibitors in geriatric depression.
Topics: 1-Naphthylamine; Age Factors; Aged; Controlled Clinical Trials as Topic; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
The role of sertraline in a patient with recurrent hyponatremia.
Topics: 1-Naphthylamine; Aged; Antidepressive Agents; Depressive Disorder; Female; Humans; Hyponatremia; Recurrence; Sertraline | 1996 |
Depression: making the diagnosis and using SSRIs in the older patient.
Topics: 1-Naphthylamine; Adult; Aged; Alzheimer Disease; Depressive Disorder; Diagnosis, Differential; Dose-Response Relationship, Drug; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Movement disorders associated with the serotonin selective reuptake inhibitors.
Topics: 1-Naphthylamine; Adult; Age Factors; Aged; Akathisia, Drug-Induced; Depressive Disorder; Dyskinesia, Drug-Induced; Dystonia; Female; Fluoxetine; Fluvoxamine; Humans; Male; MEDLINE; Middle Aged; Parkinson Disease, Secondary; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; United States | 1996 |
Anxiety symptoms and anxiety disorders: how are they related to premenstrual disorders?
Topics: 1-Naphthylamine; Adult; Age of Onset; Anxiety; Anxiety Disorders; Buspirone; Carbon Dioxide; Comorbidity; Depressive Disorder; Diagnosis, Differential; Female; Humans; Mental Disorders; Panic Disorder; Piperazines; Premenstrual Syndrome; Psychotherapy; Risk Factors; Sertraline; Sodium Lactate; Triazoles | 1997 |
Sertraline-induced behavioral activation during the treatment of an adolescent with major depression.
Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Anxiety; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Hyperkinesis; Hyperventilation; Psychiatric Status Rating Scales; Sertraline; Severity of Illness Index | 1996 |
Bupropion sustained release: a therapeutic overview.
Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Bupropion; Clinical Trials as Topic; Delayed-Action Preparations; Depressive Disorder; Drug Administration Schedule; Humans; Placebos; Serotonin Agents; Sertraline; Treatment Outcome | 1998 |
Depressive symptoms associated with gonadotropin-releasing hormone agonists.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Double-Blind Method; Endometriosis; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Nafarelin; Randomized Controlled Trials as Topic; Sertraline | 1998 |
Antidepressant response in late-life depression.
Topics: 1-Naphthylamine; Age Factors; Aged; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Middle Aged; Nortriptyline; Paroxetine; Patient Dropouts; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1998 |
Dysphoric disorders in women: a case of perinatal depression.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Breast Feeding; Depression, Postpartum; Depressive Disorder; Female; Humans; Pregnancy; Pregnancy Complications; Psychotic Disorders; Sertraline | 1998 |
Sertraline. A pharmacoeconomic evaluation of its use in depression.
Topics: 1-Naphthylamine; Antidepressive Agents; Antidepressive Agents, Tricyclic; Costs and Cost Analysis; Depressive Disorder; Humans; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Social functioning in depression: a review.
Topics: Adaptation, Psychological; Antidepressive Agents; Clinical Trials as Topic; Cost of Illness; Depressive Disorder; Health Status; Humans; Imipramine; Psychiatric Status Rating Scales; Psychotherapy; Quality of Life; Research Design; Sertraline; Social Adjustment; Treatment Outcome | 2000 |
Pharmacoeconomic studies of antidepressants: focus on venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Buspirone; Clinical Trials as Topic; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder; Drug Tolerance; Fluoxetine; Fluvoxamine; Humans; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
Psychopharmacologic treatment of adolescent depression.
Topics: Adolescent; Child; Cyclohexanols; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2001 |
The effects of antidepressants on sexual functioning in depressed patients: a review.
Topics: Adult; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Sexual Dysfunctions, Psychological; Sexuality; Single-Blind Method; Triazoles | 2001 |
Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Depressive Disorder; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1992 |
The acute and long-term treatment of major depression.
Topics: 1-Naphthylamine; Depressive Disorder; Follow-Up Studies; Humans; Long-Term Care; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Sertraline | 1992 |
Sertraline: a new serotonergic antidepressant.
Topics: 1-Naphthylamine; Animals; Depressive Disorder; Humans; Obsessive-Compulsive Disorder; Sertraline | 1992 |
Serotonin reuptake inhibitors are the treatment of choice in obsessive compulsive disorder.
Topics: 1-Naphthylamine; Behavior Therapy; Clomipramine; Combined Modality Therapy; Depressive Disorder; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Serotonin Antagonists; Sertraline | 1992 |
Somatic therapy for major depressive disorder: selection of an antidepressant.
Topics: 1-Naphthylamine; Antidepressive Agents; Bupropion; Depressive Disorder; Humans; Nortriptyline; Sertraline; Tranylcypromine; Trazodone | 1992 |
Pharmacokinetics of the selective serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Serotonin Antagonists; Sertraline | 1992 |
The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor.
Topics: 1-Naphthylamine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; In Vitro Techniques; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Serotonin Antagonists; Sertraline | 1992 |
Pharmacotherapy of obsessive compulsive disorder.
Topics: 1-Naphthylamine; Antidepressive Agents; Clomipramine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Paroxetine; Piperidines; Serotonin; Sertraline | 1992 |
The influence of different relapse criteria on the assessment of long-term efficacy of sertraline.
Topics: 1-Naphthylamine; Antidepressive Agents; Depressive Disorder; Follow-Up Studies; Humans; Long-Term Care; Personality Tests; Recurrence; Sertraline | 1991 |
Toleration and safety of sertraline: experience worldwide.
Topics: 1-Naphthylamine; Amitriptyline; Antidepressive Agents; Depressive Disorder; Desipramine; Drug Overdose; Humans; Risk Factors; Sertraline | 1991 |
Clinical overview of serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Antidepressive Agents, Tricyclic; Depressive Disorder; Fluoxetine; Humans; Paroxetine; Piperidines; Serotonin Antagonists; Sertraline; Zimeldine | 1990 |
Sertraline: a new antidepressant.
Topics: 1-Naphthylamine; Amitriptyline; Animals; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Male; Mice; Naphthalenes; Rats; Receptors, Adrenergic, beta; Receptors, Neurotransmitter; Serotonin Antagonists; Sertraline | 1988 |
Pharmacology of sertraline: a review.
Topics: 1-Naphthylamine; Animals; Behavior, Animal; Body Weight; Depressive Disorder; Humans; Naphthalenes; Obsessive-Compulsive Disorder; Rats; Serotonin Antagonists; Sertraline | 1988 |
202 trial(s) available for sertraline and Depression, Endogenous
| Article | Year |
|---|---|
[Fluvoxamine in the treatment of depressive disorders in alcohol dependence: results of randomized open-label comparative study].
Topics: Alcoholism; Citalopram; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2021 |
The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial.
Topics: Adolescent; Adult; Aged; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Primary Health Care; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Time Factors; Treatment Outcome; United Kingdom; Young Adult | 2019 |
Effects of selective serotonin reuptake inhibitors on DNA damage in patients with depression.
Topics: Adult; Case-Control Studies; Citalopram; Comet Assay; Depressive Disorder; DNA Damage; DNA Glycosylases; Female; Humans; Male; Middle Aged; Oxidative Stress; Poly (ADP-Ribose) Polymerase-1; Selective Serotonin Reuptake Inhibitors; Sertraline | 2019 |
Sertraline concentrations in pregnant women are steady and the drug transfer to their infants is low.
Topics: Adult; Antidepressive Agents; Cognitive Behavioral Therapy; Depressive Disorder; Double-Blind Method; Female; Fetal Blood; Humans; Infant, Newborn; Male; Milk, Human; Placenta; Postpartum Period; Pregnancy; Pregnancy Trimesters; Prenatal Exposure Delayed Effects; Sertraline | 2021 |
Clinical efficacy and safety of the Shugan Jieyu capsule in patients with acute myocardial infarction and depression.
Topics: Aged; Antidepressive Agents; Depressive Disorder; Drugs, Chinese Herbal; Female; Humans; Male; Middle Aged; Myocardial Infarction; Sertraline; Treatment Outcome | 2016 |
Transcranial direct current stimulation of 20- and 30-minutes combined with sertraline for the treatment of depression.
Topics: Adult; Affect; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Cognition; Combined Modality Therapy; Depressive Disorder; Female; Humans; Male; Prefrontal Cortex; Sertraline; Single-Blind Method; Time Factors; Transcranial Direct Current Stimulation; Treatment Outcome | 2018 |
Effectiveness of community-based depression intervention programme (ComDIP) to manage women with depression in primary care- randomised control trial.
Topics: Adult; Antidepressive Agents; Community Health Services; Depressive Disorder; Female; Humans; India; Middle Aged; Outcome and Process Assessment, Health Care; Primary Health Care; Psychotherapy; Sertraline | 2018 |
Agomelatine and sertraline for the treatment of depression in type 2 diabetes mellitus.
Topics: Acetamides; Adolescent; Adult; Antidepressive Agents; Anxiety Disorders; Depressive Disorder; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Middle Aged; Pilot Projects; Self Care; Sertraline; Treatment Outcome; Young Adult | 2013 |
The external validity of MRI-defined vascular depression.
Topics: Age Factors; Aged; Aged, 80 and over; Antidepressive Agents; Cerebrovascular Disorders; Depressive Disorder; Double-Blind Method; Female; Geriatric Assessment; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Nortriptyline; Psychiatric Status Rating Scales; Psychomotor Performance; Reproducibility of Results; Sertraline; Sex Factors | 2013 |
Persistent sleep disturbance is associated with treatment response in adolescents with depression.
Topics: Adolescent; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Female; Humans; Male; Sertraline; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 2013 |
Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial.
Topics: Adult; Antidepressive Agents; Combined Modality Therapy; Cytokines; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Sertraline; Transcranial Direct Current Stimulation; Treatment Outcome | 2014 |
Sertraline and periodic limb movements during sleep: an 8-week open-label study in depressed patients with insomnia.
Topics: Adult; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Nocturnal Myoclonus Syndrome; Polysomnography; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Initiation and Maintenance Disorders; Sleep Stages; Young Adult | 2013 |
Effects of antidepressant medication on emotion regulation in depressed patients: an iSPOT-D report.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Citalopram; Cyclohexanols; Depressive Disorder; Emotions; Female; Humans; Male; Middle Aged; Repression, Psychology; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2014 |
Impairment and distress patterns distinguishing the melancholic depression subtype: an iSPOT-D report.
Topics: Adaptation, Psychological; Adolescent; Adult; Aged; Citalopram; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Risk Factors; Sertraline; Symptom Assessment; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2015 |
Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial.
Topics: Adult; Antidepressive Agents; Anxiety; Citalopram; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Outpatients; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2015 |
Depression care management for adults older than 60 years in primary care clinics in urban China: a cluster-randomised trial.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Bupropion; China; Depressive Disorder; Health Policy; Humans; Middle Aged; Patient Care Management; Primary Health Care; Psychiatric Status Rating Scales; Sertraline; Treatment Outcome | 2015 |
The effect of flexible cognitive-behavioural therapy and medical treatment, including antidepressants on post-traumatic stress disorder and depression in traumatised refugees: pragmatic randomised controlled clinical trial.
Topics: Adult; Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Denmark; Depressive Disorder; Female; Humans; Male; Mianserin; Middle Aged; Patient Education as Topic; Psychiatric Status Rating Scales; Quality of Life; Refugees; Sertraline; Stress Disorders, Post-Traumatic; Treatment Outcome | 2016 |
Sertraline for Preventing Mood Disorders Following Traumatic Brain Injury: A Randomized Clinical Trial.
Topics: Adult; Aged; Brain Injuries, Traumatic; Cross-Sectional Studies; Denmark; Depressive Disorder; Double-Blind Method; Female; Follow-Up Studies; Hospitals, University; Humans; Intention to Treat Analysis; Male; Middle Aged; Registries; Sertraline; Treatment Outcome; Young Adult | 2016 |
Effect of memantine combination therapy on symptoms in patients with moderate-to-severe depressive disorder: randomized, double-blind, placebo-controlled study.
Topics: Adult; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Memantine; Psychiatric Status Rating Scales; Receptors, N-Methyl-D-Aspartate; Sertraline; Treatment Outcome | 2017 |
Sertraline Reduces Risk of Depression in Adults After Traumatic Brain Injury.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Injuries, Traumatic; Depressive Disorder; Double-Blind Method; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult | 2017 |
Motor changes during sertraline treatment in depressed patients with Parkinson's disease*.
Topics: Aged; Antidepressive Agents, Second-Generation; Antiparkinson Agents; Cohort Studies; Depression; Depressive Disorder; Dopamine; Drug Interactions; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Prospective Studies; Quality of Life; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Severity of Illness Index | 2008 |
Smoking behavior postmyocardial infarction among ENRICHD trial participants: cognitive behavior therapy intervention for depression and low perceived social support compared with care as usual.
Topics: Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Depressive Disorder, Major; Dysthymic Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Personality Inventory; Sertraline; Sick Role; Smoking; Smoking Cessation; Social Support | 2008 |
Sertraline in the treatment of depressive disorders in patients with Parkinson's disease.
Topics: Aged; Brain; Brain Chemistry; Deglutition Disorders; Depressive Disorder; Dopamine; Dopamine Uptake Inhibitors; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Parkinson Disease; Recovery of Function; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Surveys and Questionnaires; Treatment Outcome | 2008 |
A randomized controlled trial of sertraline for the treatment of depression in persons with traumatic brain injury.
Topics: Adult; Antidepressive Agents; Brain Injuries; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Probability; Psychiatric Status Rating Scales; Quality of Life; Reference Values; Risk Assessment; Sertraline; Treatment Outcome | 2009 |
Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression.
Topics: Adult; Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Predictive Value of Tests; Prospective Studies; Sertraline; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2010 |
Effects of SNS activation on SSRI-induced sexual side effects differ by SSRI.
Topics: Adrenergic Agents; Adult; Arousal; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Ephedrine; Female; Fluoxetine; Humans; Norepinephrine; Orgasm; Paroxetine; Premedication; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Sexual Behavior; Sexual Dysfunction, Physiological; Sympathetic Nervous System | 2009 |
Depression and comorbid panic in primary care patients.
Topics: Adult; Comorbidity; Depressive Disorder; Female; Fluoxetine; Humans; Longitudinal Studies; Male; Middle Aged; Multicenter Studies as Topic; Panic Disorder; Paroxetine; Primary Health Care; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States | 2010 |
Depression treatment and its impact upon the quality of life in patients with diabetes type 2 - the Croatian study.
Topics: Adult; Antidepressive Agents; Chronic Disease; Comorbidity; Croatia; Cross-Sectional Studies; Depressive Disorder; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Male; Personality Inventory; Psychometrics; Quality of Life; Sertraline; Surveys and Questionnaires | 2010 |
Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS-2)?
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Depressive Disorder; Female; Humans; Male; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline | 2011 |
Effect of omega-3 fatty acids on heart rate variability in depressed patients with coronary heart disease.
Topics: Circadian Rhythm; Comorbidity; Coronary Disease; Depressive Disorder; Drug Therapy, Combination; Electrocardiography, Ambulatory; Fatty Acids, Omega-3; Female; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Placebos; Sertraline; Treatment Outcome | 2010 |
Cholesterol concentrations and clinical response to sertraline in patients with epilepsy: preliminary results.
Topics: Adult; Cholesterol; Depressive Disorder; Dose-Response Relationship, Drug; Epilepsy, Temporal Lobe; Female; Follow-Up Studies; Humans; Linear Models; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide, Attempted | 2010 |
Treatment of atypical depression: post-hoc analysis of a randomized controlled study testing the efficacy of sertraline and cognitive behavioural therapy in mildly depressed outpatients.
Topics: Adult; Antidepressive Agents; Cognitive Behavioral Therapy; Depressive Disorder; Double-Blind Method; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; Outpatients; Patient Selection; Psychiatric Status Rating Scales; Self-Help Groups; Sertraline; Severity of Illness Index; Single-Blind Method; Treatment Outcome | 2010 |
Are treatment preferences relevant in response to serotonergic antidepressants and cognitive-behavioral therapy in depressed primary care patients? Results from a randomized controlled trial including a patients' choice arm.
Topics: Adult; Cognitive Behavioral Therapy; Depressive Disorder; Female; Germany; Humans; Male; Middle Aged; Patient Preference; Primary Health Care; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2011 |
Outcome of adolescent depression: 6 months after treatment.
Topics: Adolescent; Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Follow-Up Studies; Humans; Male; Prognosis; Self Efficacy; Sertraline; Surveys and Questionnaires; Treatment Outcome | 2011 |
Poor response to sertraline in methamphetamine dependence is associated with sustained craving for methamphetamine.
Topics: Adult; Amphetamine-Related Disorders; Antidepressive Agents; Behavior, Addictive; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Methamphetamine; Middle Aged; Sertraline; Treatment Outcome | 2011 |
Serum BDNF levels before treatment predict SSRI response in depression.
Topics: Adult; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Cross-Over Studies; Depression; Depressive Disorder; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method; Treatment Outcome | 2011 |
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Dementia; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Mental Disorders; Mianserin; Mirtazapine; Randomized Controlled Trials as Topic; Sertraline | 2011 |
Change in cognitive functioning in depressed older adults following treatment with sertraline or nortriptyline.
Topics: Adrenergic Uptake Inhibitors; Aged; Antidepressive Agents; Attention; Cognition; Depressive Disorder; Double-Blind Method; Executive Function; Female; Humans; Male; Memory; Middle Aged; Nortriptyline; Psychomotor Performance; Selective Serotonin Reuptake Inhibitors; Sertraline | 2012 |
Bupropion versus sertraline in the treatment of depressive patients with binge eating disorder: retrospective cohort study.
Topics: Adult; Antidepressive Agents; Binge-Eating Disorder; Body Mass Index; Bupropion; Depressive Disorder; Female; Humans; Male; Overweight; Psychiatric Status Rating Scales; Retrospective Studies; Sertraline; Sexual Dysfunctions, Psychological; Treatment Outcome; Weight Loss | 2012 |
Sensitivity to changes during antidepressant treatment: a comparison of unidimensional subscales of the Inventory of Depressive Symptomatology (IDS-C) and the Hamilton Depression Rating Scale (HAMD) in patients with mild major, minor or subsyndromal depre
Topics: Adult; Antidepressive Agents; Cognitive Behavioral Therapy; Depression; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Diagnostic Errors; Drug Monitoring; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Psychological Tests; Sensitivity and Specificity; Sertraline; Treatment Outcome; Weights and Measures | 2012 |
Impact of psychotherapy and antidepressive treatment on cognitive functions in patients treated for depression.
Topics: Antidepressive Agents; Attention; Cognition Disorders; Combined Modality Therapy; Depressive Disorder; Humans; Memory, Short-Term; Neuropsychological Tests; Poland; Psychoanalytic Therapy; Psychometrics; Psychotherapy, Group; Recurrence; Sertraline; Signal Detection, Psychological; Treatment Outcome | 2012 |
Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Ambulatory Care Facilities; Antidepressive Agents; Cognition; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Neuropsychological Tests; Sertraline; Treatment Outcome | 2012 |
Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST).
Topics: Adult; Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors; Sertraline; Treatment Outcome; Young Adult | 2013 |
The clinical profile of older patients' response to antidepressants--an open trial of sertraline.
Topics: Aged; Aged, 80 and over; Aging; Antidepressive Agents; Depressive Disorder; Female; Forecasting; Humans; Male; Prognosis; Sertraline; Severity of Illness Index; Treatment Outcome | 2002 |
Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo.
Topics: Adult; Antidepressive Agents; Chronic Disease; Depressive Disorder; Double-Blind Method; Female; Health Status; Humans; Longitudinal Studies; Male; Outcome Assessment, Health Care; Personality Inventory; Placebos; Quality of Life; Sertraline; Social Adjustment; Substance Withdrawal Syndrome; Treatment Outcome | 2002 |
Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man.
Topics: Adult; Attention; Cross-Over Studies; Depressive Disorder; Dopamine Uptake Inhibitors; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
A randomized trial of sertraline as a cessation aid for smokers with a history of major depression.
Topics: Adult; Behavior, Addictive; Comorbidity; Depressive Disorder; Female; Humans; Male; Middle Aged; Placebos; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Smoking; Smoking Cessation; Smoking Prevention; Substance Withdrawal Syndrome; Treatment Outcome | 2002 |
Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study.
Topics: Antipsychotic Agents; Benzodiazepines; Combat Disorders; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Fluoxetine; Humans; Male; Middle Aged; Olanzapine; Paroxetine; Pirenzepine; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Wake Disorders; Treatment Outcome | 2002 |
MRI subcortical hyperintensities in old and very old depressed outpatients: the important role of age in late-life depression.
Topics: Age of Onset; Aged; Aging; Antidepressive Agents, Second-Generation; Brain; Citalopram; Dementia, Vascular; Depressive Disorder; Female; Humans; Magnetic Resonance Imaging; Male; Outpatients; Psychiatric Status Rating Scales; Risk Factors; Sertraline; Treatment Outcome | 2002 |
Treating depression after a heart attack.
Topics: Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Male; Myocardial Infarction; Reference Values; Sertraline; Severity of Illness Index; Treatment Outcome | 2002 |
Sertraline treatment of elderly patients with depression and cognitive impairment.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Cognition Disorders; Depressive Disorder; Drug Administration Schedule; Female; Follow-Up Studies; Geriatric Assessment; Humans; Male; Middle Aged; Neuropsychological Tests; Psychiatric Status Rating Scales; Sertraline; Treatment Outcome | 2003 |
Chronic depression and comorbid personality disorders: response to sertraline versus imipramine.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Chronic Disease; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Personality Disorders; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Survival Analysis; Treatment Outcome | 2003 |
Older community residents with depression: long-term treatment with sertraline. Randomised, double-blind, placebo-controlled study.
Topics: Age Factors; Aged; Aged, 80 and over; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Patient Compliance; Recurrence; Regression Analysis; Sertraline; Treatment Outcome | 2003 |
SSRIs in the treatment of depression in Parkinson's disease.
Topics: Aged; Analysis of Variance; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Parkinson Disease; Psychiatric Status Rating Scales; Psychomotor Performance; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2003 |
Sertraline versus imipramine treatment of comorbid panic disorder and major depressive disorder.
Topics: Adult; Antidepressive Agents, Tricyclic; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Panic Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2003 |
Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Ambulatory Care; Caregivers; Cognition Disorders; Comorbidity; Depressive Disorder; Drug Administration Schedule; Female; Geriatric Assessment; Humans; Male; Mental Disorders; Neuropsychological Tests; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method; Treatment Outcome | 2003 |
Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bupropion; Carrier Proteins; Case-Control Studies; Circadian Rhythm; Depressive Disorder; Dopamine Uptake Inhibitors; Female; Humans; Intracellular Signaling Peptides and Proteins; Male; Neuropeptides; Orexins; Radioimmunoassay; Selective Serotonin Reuptake Inhibitors; Sertraline | 2003 |
A pilot, open study of sertraline in outpatients with treatment-resistant depression (TRD) or with a history of TRD who responded but later relapsed.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Female; Humans; Male; Middle Aged; Recurrence; Sertraline; Severity of Illness Index; Treatment Outcome | 2003 |
Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Prospective Studies; Psychiatric Status Rating Scales; Sertraline; Sexual Dysfunction, Physiological; Time Factors | 2003 |
A comparison of antidepressant response in younger and older women.
Topics: Adult; Aged; Aging; Antidepressive Agents; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Sertraline; Sex Characteristics; Triazoles | 2003 |
Probing the safety of medications in the frail elderly: evidence from a randomized clinical trial of sertraline and venlafaxine in depressed nursing home residents.
Topics: Aged; Aged, 80 and over; Cyclohexanols; Depressive Disorder; Female; Frail Elderly; Geriatric Assessment; Humans; Male; Middle Aged; Nursing Homes; Patient Dropouts; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
Sertraline as monotherapy in the treatment of psychotic and nonpsychotic depression.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Aged; Brief Psychiatric Rating Scale; Depressive Disorder; Female; Hospitalization; Humans; Male; Middle Aged; Practice Guidelines as Topic; Practice Patterns, Physicians'; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Treatment Outcome | 2003 |
Effects of an educational compliance enhancement programme and therapeutic drug monitoring on treatment adherence in depressed patients managed by general practitioners.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Data Collection; Depressive Disorder; Family Practice; Female; Humans; Male; Middle Aged; Patient Compliance; Patient Education as Topic; Patient Satisfaction; Psychiatric Status Rating Scales; Sertraline; Sweden | 2003 |
Does antidepressant therapy improve cognition in elderly depressed patients?
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Cognition; Cognition Disorders; Confidence Intervals; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Middle Aged; Neuropsychological Tests; Nortriptyline; Probability; Reference Values; Sertraline; Severity of Illness Index; Single-Blind Method; Statistics, Nonparametric; Treatment Outcome | 2003 |
Efficacy, safety, and tolerability of sertraline in patients with late-life depression and comorbid medical illness.
Topics: Aged; Analysis of Variance; Antidepressive Agents; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Health Status Indicators; Humans; Male; Middle Aged; Quality of Life; Sertraline; Treatment Outcome | 2004 |
Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Humans; Imipramine; Male; Patient Acceptance of Health Care; Psychiatric Status Rating Scales; Sertraline; Sex Characteristics; Socioeconomic Factors | 2004 |
A randomized, placebo-controlled trial of sertraline for prophylactic treatment of highly recurrent major depressive disorder.
Topics: Adult; Clinical Protocols; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Placebos; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2004 |
The outcome of physical symptoms with treatment of depression.
Topics: Depressive Disorder; Female; Fluoxetine; Follow-Up Studies; Health Status; Health Surveys; Humans; Male; Middle Aged; Paroxetine; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Somatoform Disorders; Treatment Outcome | 2004 |
Adjunctive bright light in non-seasonal major depression.
Topics: Adult; Algorithms; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Phototherapy; Sertraline | 2004 |
Efficacy and tolerability of hypericum extract STW3 in long-term treatment with a once-daily dosage in comparison with sertraline.
Topics: Adolescent; Adult; Aged; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Female; Humans; Hypericum; International Classification of Diseases; Male; Middle Aged; Phytotherapy; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Time | 2005 |
Pharmacoeconomic analysis of sertraline treatment of depression in patients with unstable angina or a recent myocardial infarction.
Topics: Angina, Unstable; Cardiac Catheterization; Cost-Benefit Analysis; Depressive Disorder; Diagnosis-Related Groups; Double-Blind Method; Drug Costs; Emergency Service, Hospital; Fee Schedules; Female; Health Care Costs; Hospital Costs; Hospitalization; Humans; Male; Medicare; Middle Aged; Myocardial Infarction; Outcome Assessment, Health Care; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline | 2005 |
Citalopram versus sertraline in late-life nonmajor clinically significant depression: a 1-year follow-up clinical trial.
Topics: Age Factors; Aged; Citalopram; Cognition Disorders; Depressive Disorder; Female; Follow-Up Studies; Geriatric Assessment; Humans; Male; Neuropsychological Tests; Psychiatric Status Rating Scales; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Trail Making Test; Treatment Outcome; Wechsler Scales | 2005 |
Double-blind comparison of sertraline and placebo in stroke patients with minor depression and less severe major depression.
Topics: Aged; Aged, 80 and over; Ambulatory Care; Depressive Disorder; Depressive Disorder, Major; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Stroke; Treatment Outcome | 2005 |
Adjunctive bright light in non-seasonal major depression: results from clinician-rated depression scales.
Topics: Adult; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Phototherapy; Psychiatric Status Rating Scales; Psychometrics; Sertraline; Severity of Illness Index; Survival Analysis; Time Factors | 2005 |
Treatment for depression and its relationship to improvement in quality of life and psychological well-being in multiple sclerosis patients.
Topics: Adult; Antidepressive Agents; Behavior Therapy; Depressive Disorder; Female; Humans; Male; Multiple Sclerosis; Psychotherapy, Group; Quality of Life; Regression Analysis; Sertraline; Severity of Illness Index; Sickness Impact Profile | 2005 |
[Comparison of reboxetine and sertraline in terms of efficacy and safety in major depressive disorder].
Topics: Adolescent; Adult; Aged; Depressive Disorder; Female; Humans; Male; Middle Aged; Morpholines; Psychiatric Status Rating Scales; Reboxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2005 |
Central neurochemical ultradian variability in depression.
Topics: Adult; Antidepressive Agents; Bupropion; Depressive Disorder; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Prognosis; Sertraline; Tryptophan | 2006 |
A comparative study of sertraline dosages, plasma concentrations, efficacy and adverse reactions in Chinese versus Caucasian patients.
Topics: Adult; Antidepressive Agents; Asian People; Australia; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Kinetics; Malaysia; Male; Middle Aged; Prospective Studies; Sertraline; White People | 2006 |
Serotonin transporter polymorphisms and clinical response to sertraline across ethnicities.
Topics: Adult; Alleles; Antidepressive Agents, Second-Generation; Asian People; Australia; China; Depressive Disorder; DNA; Ethnicity; Female; Gene Frequency; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic; Prospective Studies; Psychiatric Status Rating Scales; Serotonin Plasma Membrane Transport Proteins; Sertraline; White People | 2006 |
A pilot study of sertraline for depression in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Depressive Disorder; Female; Humans; Macular Degeneration; Male; Pilot Projects; Sertraline | 2006 |
Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.
Topics: Adjuvants, Pharmaceutic; Adult; Affect; Antidepressive Agents; Antidepressive Agents, Second-Generation; Bipolar Disorder; Bupropion; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Risk Factors; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2006 |
Preventing depression after stroke: Results from a randomized placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Incidence; Male; Middle Aged; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Stroke; Treatment Outcome | 2006 |
Comparison of three rating scales as outcome measures for treatment trials of depression in Alzheimer disease: findings from DIADS.
Topics: Aged; Alzheimer Disease; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Statistics as Topic; Treatment Outcome | 2006 |
Design of Depression in Alzheimer's Disease Study-2.
Topics: Affect; Aged; Alzheimer Disease; Antidepressive Agents, Second-Generation; Caregivers; Combined Modality Therapy; Cost of Illness; Counseling; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Patient Dropouts; Problem Solving; Quality Assurance, Health Care; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Support; Treatment Outcome | 2006 |
Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 2007 |
Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: a placebo-controlled double-blind randomised trial.
Topics: Aged; Antidepressive Agents; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms; Placebos; Psychiatric Status Rating Scales; Quality of Life; Sertraline; Survival Rate; Treatment Outcome | 2007 |
Sertraline effectiveness and safety in depressed oncological patients.
Topics: Adult; Aged; Antidepressive Agents; Antineoplastic Agents; Anxiety; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Neoplasms; Pilot Projects; Prospective Studies; Psychiatric Status Rating Scales; Quality of Life; Sertraline; Severity of Illness Index; Time Factors | 2008 |
Predictors of treatment response for depression and inadequate social support--the ENRICHD randomized clinical trial.
Topics: Adult; Aged; Antidepressive Agents; Assertiveness; Cognitive Behavioral Therapy; Combined Modality Therapy; Communication; Coronary Disease; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Personality Inventory; Sertraline; Social Support; Treatment Outcome | 2008 |
Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study.
Topics: Aged; Antidepressive Agents; Cholinesterase Inhibitors; Cognition Disorders; Depressive Disorder; Donepezil; Epidemiologic Methods; Female; Humans; Indans; Male; Middle Aged; Neuropsychological Tests; Nootropic Agents; Piperidines; Sertraline; Treatment Outcome | 2008 |
Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday.
Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Sexual Dysfunctions, Psychological | 1995 |
A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression.
Topics: 1-Naphthylamine; Adult; Age Factors; Ambulatory Care; Bipolar Disorder; Depressive Disorder; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; Nausea; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1995 |
Are patients who are intolerant to one serotonin selective reuptake inhibitor intolerant to another?
Topics: 1-Naphthylamine; Adult; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Female; Fluoxetine; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method | 1995 |
Sertraline pharmacotherapy for paraphilias and paraphilia-related disorders: an open trial.
Topics: 1-Naphthylamine; Adult; Depressive Disorder; Fluoxetine; Humans; Male; Middle Aged; Paraphilic Disorders; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Sexual Behavior; Treatment Outcome | 1994 |
An unusual indication for a single-subject clinical trial.
Topics: 1-Naphthylamine; Clinical Trials as Topic; Combined Modality Therapy; Cross-Over Studies; Depressive Disorder; Humans; Male; Middle Aged; Physician-Patient Relations; Placebos; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Self Concept; Sertraline; Transference, Psychology; Treatment Outcome | 1994 |
Effects of sertraline on mood and immune status in patients with major depression and HIV illness: an open trial.
Topics: 1-Naphthylamine; Affect; Antidepressive Agents; CD4 Lymphocyte Count; Comorbidity; Depressive Disorder; Female; HIV Infections; Humans; Immunity; Killer Cells, Natural; Leukocyte Count; Male; Psychiatric Status Rating Scales; Sertraline; T-Lymphocyte Subsets; T-Lymphocytes; Treatment Outcome | 1994 |
Childhood psychopathology retrospectively assessed among adults with early onset major depression.
Topics: 1-Naphthylamine; Adolescent; Adult; Anxiety Disorders; Child; Child Behavior Disorders; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Imipramine; Male; Mental Disorders; Middle Aged; Paroxetine; Personality Development; Phobic Disorders; Recurrence; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Management of depression in real-life settings: knowledge gained from large-scale clinical trials.
Topics: 1-Naphthylamine; Adolescent; Adult; Aged; Depressive Disorder; Dose-Response Relationship, Drug; Dothiepin; Double-Blind Method; Drug Administration Schedule; Family Practice; Female; Humans; Male; Middle Aged; Personality Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Quality of life: experience with sertraline.
Topics: 1-Naphthylamine; Adolescent; Adult; Aged; Cost-Benefit Analysis; Depressive Disorder; Disability Evaluation; Dothiepin; Family Practice; Female; Humans; Male; Middle Aged; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
A double-blind, placebo-controlled comparison of sertraline and dothiepin in the treatment of major depression in general practice.
Topics: 1-Naphthylamine; Analysis of Variance; Antidepressive Agents; Depressive Disorder; Dothiepin; Double-Blind Method; Family Practice; Female; Humans; Male; Middle Aged; Sertraline | 1994 |
Sertraline efficacy in depressed combat veterans with posttraumatic stress disorder.
Topics: 1-Naphthylamine; Adult; Comorbidity; Depressive Disorder; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic | 1994 |
Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression.
Topics: 1-Naphthylamine; Adult; Aged; Analysis of Variance; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 1993 |
Combined SSRI-moclobemide treatment of psychiatric illness.
Topics: 1-Naphthylamine; Adult; Benzamides; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Male; Mental Disorders; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Obsessive-Compulsive Disorder; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Sertraline versus desipramine in the treatment of premenstrual syndrome: an open-label trial.
Topics: 1-Naphthylamine; Adolescent; Adult; Depressive Disorder; Desipramine; Double-Blind Method; Female; Humans; Middle Aged; Premenstrual Syndrome; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 1996 |
Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo.
Topics: 1-Naphthylamine; Adolescent; Adult; Aged; Analysis of Variance; Antidepressive Agents; Body Weight; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nausea; Sertraline; Treatment Outcome; Tremor | 1995 |
Response to an open trial of a second SSRI in major depression.
Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Measurement of treatment response to sertraline in depressed multiple sclerosis patients using the Carroll scale.
Topics: 1-Naphthylamine; Analysis of Variance; Antidepressive Agents; Depressive Disorder; Humans; Middle Aged; Multiple Sclerosis; Prospective Studies; Self-Assessment; Sertraline; Treatment Outcome | 1995 |
Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression.
Topics: 1-Naphthylamine; Adrenergic Uptake Inhibitors; Antidepressive Agents; Brain; Brain Chemistry; Depressive Disorder; Desipramine; Diphenhydramine; Dopamine; Fluoxetine; Humans; Mazindol; Methyltyrosines; Norepinephrine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia.
Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Chronic Disease; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imipramine; Male; Middle Aged; Personality Inventory; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Improvement in subjective work performance after treatment of chronic depression: some preliminary results. Chronic Depression Study Group.
Topics: 1-Naphthylamine; Antidepressive Agents; Chronic Disease; Depressive Disorder; Humans; Imipramine; Psychiatric Status Rating Scales; Sertraline; Task Performance and Analysis | 1996 |
Sertraline in the treatment of premenstrual dysphoric disorder.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Depressive Disorder; Female; Humans; Premenstrual Syndrome; Psychiatric Status Rating Scales; Sertraline | 1996 |
Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression.
Topics: 1-Naphthylamine; Delusions; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Hospitalization; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Effect of sertraline on regional metabolic rate in patients with affective disorder.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Blood Glucose; Brain Mapping; Cerebral Cortex; Deoxyglucose; Depressive Disorder; Dominance, Cerebral; Energy Metabolism; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Personality Inventory; Sertraline; Thalamus; Tomography, Emission-Computed | 1997 |
Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline.
Topics: 1-Naphthylamine; Adult; Ambulatory Care; Depressive Disorder; Female; Fluoxetine; Humans; Male; Prospective Studies; Psychiatric Status Rating Scales; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Failure; Treatment Outcome | 1997 |
Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS. Improvements in affective and somatic symptoms.
Topics: 1-Naphthylamine; Acquired Immunodeficiency Syndrome; Adaptation, Psychological; Adult; Depressive Disorder; Female; Fluoxetine; HIV Infections; Humans; Male; Middle Aged; Paroxetine; Patient Care Team; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Sertraline; Sick Role; Somatoform Disorders | 1997 |
A double-blind study of long-term treatment with sertraline or fluvoxamine for prevention of highly recurrent unipolar depression.
Topics: 1-Naphthylamine; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Fluvoxamine; Follow-Up Studies; Humans; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
A preliminary study on the efficacy of sertraline and imipramine on anger attacks in atypical depression and dysthymia.
Topics: 1-Naphthylamine; Adult; Aged; Anger; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Dysthymic Disorder; Female; Humans; Imipramine; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline | 1997 |
Six month follow-up of early-onset chronic depression.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Chronic Disease; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Patient Discharge; Prognosis; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors.
Topics: 1-Naphthylamine; Adult; Compulsive Behavior; Dementia; Depressive Disorder; Female; Fluoxetine; Frontal Lobe; Humans; Impulsive Behavior; Male; Middle Aged; Paroxetine; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Temporal Lobe; Treatment Outcome | 1997 |
Sertraline in coexisting major depression and diabetes mellitus.
Topics: 1-Naphthylamine; Blood Platelets; Depressive Disorder; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Single-Blind Method | 1997 |
Differential pharmacological treatment response in high angry hostile and low angry hostile depressed patients: a retrospective analysis.
Topics: 1-Naphthylamine; Adult; Ambulatory Care; Analysis of Variance; Anger; Cyclohexanols; Depressive Disorder; Desipramine; Female; Hostility; Humans; Male; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
A novel placebo lead-in behavior strategy for sertraline dosing in a depressed patient highly sensitive to medication side effects.
Topics: 1-Naphthylamine; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Middle Aged; Patient Compliance; Placebos; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression.
Topics: 1-Naphthylamine; Adult; Ambulatory Care; Amitriptyline; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Health Status Indicators; Humans; Male; Patient Compliance; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients.
Topics: 1-Naphthylamine; Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents; Bupropion; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; Nausea; Psychiatric Status Rating Scales; Sertraline; Sexual Dysfunctions, Psychological; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 1997 |
Use of SSRIs in "very old" depressed nursing home residents.
Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Alzheimer Disease; Central Nervous System Diseases; Dementia, Vascular; Depressive Disorder; Female; Fluoxetine; Homes for the Aged; Humans; Male; Matched-Pair Analysis; New York; Nursing Homes; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Statistics, Nonparametric | 1998 |
Immune markers in fibromyalgia: comparison with major depressed patients and normal volunteers.
Topics: 1-Naphthylamine; Adult; Analysis of Variance; Creatinine; Depressive Disorder; Double-Blind Method; Female; Fibromyalgia; Humans; Immunity, Cellular; Male; Middle Aged; Neopterin; Pseudouridine; Selective Serotonin Reuptake Inhibitors; Sertraline; Uric Acid | 1998 |
Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial.
Topics: 1-Naphthylamine; Adult; Comorbidity; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Luteal Phase; Medical Records; Personality Inventory; Placebos; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires | 1998 |
A randomized, double-blind crossover trial of sertraline in women with chronic pelvic pain.
Topics: 1-Naphthylamine; Adult; Chronic Disease; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Female; Humans; Middle Aged; Pain Measurement; Pelvic Pain; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Effects of comorbidity and polypharmacy on the clinical usefulness of sertraline in elderly depressed patients: an open multicentre study.
Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Ambulatory Care; Antidepressive Agents; Cardiovascular Diseases; Comorbidity; Depressive Disorder; Drug Administration Schedule; Female; Geriatric Assessment; Humans; Male; Middle Aged; Musculoskeletal Diseases; Psychiatric Status Rating Scales; Sertraline; Severity of Illness Index; Treatment Outcome | 1997 |
A double-blind multicenter trial comparing sertraline and citalopram in patients with major depression treated in general practice.
Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Citalopram; Depressive Disorder; Diarrhea; Double-Blind Method; Family Practice; Female; Humans; Male; Middle Aged; Nausea; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors | 1997 |
Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: pharmacokinetics, tolerability, and efficacy.
Topics: 1-Naphthylamine; Adolescent; Age Factors; Analysis of Variance; Child; Depressive Disorder; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
Topics: 1-Naphthylamine; Adult; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Half-Life; Health Status; Humans; Male; Middle Aged; Paroxetine; Placebos; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Substance Withdrawal Syndrome; Surveys and Questionnaires | 1998 |
A comparative study of sertraline versus imipramine in postpsychotic depressive disorder of schizophrenia.
Topics: Adult; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Personality disorder comorbidity with major depression and response to treatment with sertraline or citalopram.
Topics: Adult; Aged; Antidepressive Agents; Citalopram; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Personality Disorders; Psychiatric Status Rating Scales; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial.
Topics: Adult; Antidepressive Agents; Chronic Disease; Cost of Illness; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1998 |
Double-blind, multicenter comparative study of sertraline and amitriptyline in hospitalized patients with major depression.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Amitriptyline; Antidepressive Agents; Constipation; Depressive Disorder; Double-Blind Method; Female; Hospitalization; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Wake Disorders | 1998 |
The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies.
Topics: Antidepressive Agents, Tricyclic; Chronic Disease; Clinical Protocols; Comorbidity; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Dysthymic Disorder; Follow-Up Studies; Humans; Imipramine; Patient Dropouts; Quality of Life; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1998 |
The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine.
Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Tricyclic; Chronic Disease; Comorbidity; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Dysthymic Disorder; Female; Humans; Imipramine; Male; Middle Aged; Patient Selection; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1998 |
The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine.
Topics: Adaptation, Psychological; Adult; Antidepressive Agents, Tricyclic; Chronic Disease; Comorbidity; Depressive Disorder; Double-Blind Method; Dysthymic Disorder; Female; Follow-Up Studies; Health Status; Humans; Imipramine; Male; Middle Aged; Personal Satisfaction; Personality Inventory; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Adjustment; Surveys and Questionnaires; Treatment Outcome | 1998 |
Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine.
Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Tricyclic; Chronic Disease; Comorbidity; Depressive Disorder; Double-Blind Method; Educational Status; Female; Humans; Imipramine; Male; Middle Aged; Personality; Probability; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Social Adjustment; Treatment Outcome | 1998 |
Early augmentation of sertraline with methylphenidate.
Topics: Adult; Ambulatory Care; Central Nervous System Stimulants; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Methylphenidate; Middle Aged; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1999 |
Clinical and economic comparison of sertraline and fluoxetine in the treatment of depression. A 6-month double-blind study in a primary-care setting in France.
Topics: 1-Naphthylamine; Adolescent; Adult; Aged; Antidepressive Agents; Costs and Cost Analysis; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; France; Humans; Male; Middle Aged; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Comparative efficacy and safety of sertraline versus nortriptyline in major depression in patients 70 and older.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Antidepressive Agents; Cognition; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Male; Nortriptyline; Psychiatric Status Rating Scales; Quality of Life; Sertraline; Single-Blind Method | 1999 |
The Norwegian naturalistic treatment study of depression in general practice (NORDEP)-I: randomised double blind study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Counseling; Depressive Disorder; Double-Blind Method; Ethics, Medical; Family Practice; Female; Humans; Male; Mianserin; Middle Aged; Norway; Patient Compliance; Psychotherapy; Quality Assurance, Health Care; Sertraline; Treatment Outcome | 1999 |
Multicenter open-label sertraline study in adolescent outpatients with major depression.
Topics: Adolescent; Adult; Antidepressive Agents; Child; Depressive Disorder; Female; Humans; Male; Psychiatric Status Rating Scales; Sertraline; Severity of Illness Index; Treatment Outcome | 1999 |
An open-label trial of sertraline for the treatment of major depression in primary care.
Topics: Adolescent; Adult; Aged; Clinical Protocols; Depressive Disorder; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Middle Aged; Primary Health Care; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 1999 |
Predictors of an acute antidepressant response to fluoxetine and sertraline.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Anxiety; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Forecasting; Humans; Male; Middle Aged; Motor Activity; Prognosis; Regression Analysis; Sertraline; Treatment Outcome | 1999 |
Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Comorbidity; Depressive Disorder; Desipramine; Double-Blind Method; Drug Administration Schedule; Female; Humans; Placebos; Premenstrual Syndrome; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1999 |
Antidepressant treatment of depression in HIV-seropositive women.
Topics: Ambulatory Care; Antidepressive Agents; Comorbidity; Depressive Disorder; Female; Fluoxetine; HIV Seropositivity; Humans; Psychiatric Status Rating Scales; Sertraline; Sex Factors; Treatment Outcome | 1999 |
Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Tricyclic; Comorbidity; Depressive Disorder; Desipramine; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2000 |
A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Cognition Disorders; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Neuropsychological Tests; Nursing Homes; Sertraline; Severity of Illness Index | 2000 |
A 12-week study comparing moclobemide and sertraline in the treatment of outpatients with atypical depression.
Topics: Adult; Aged; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Outpatients; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline | 1999 |
Hormonal markers of stress response following interruption of selective serotonin reuptake inhibitor treatment.
Topics: Adult; Biomarkers; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Hemodynamics; Hormones; Humans; Male; Paroxetine; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress, Psychological; Substance Withdrawal Syndrome | 2000 |
Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.
Topics: Adult; Aged; Ambulatory Care; Cyclohexanols; Depressive Disorder; Diarrhea; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Headache; Humans; Male; Middle Aged; Nausea; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
Evaluation of sexual functioning in depressed outpatients: a double-blind comparison of sustained-release bupropion and sertraline treatment.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Bupropion; Delayed-Action Preparations; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Sertraline; Sexual Behavior | 2000 |
Randomized trial of a depression management program in high utilizers of medical care.
Topics: Antidepressive Agents; Depressive Disorder; Family Practice; Female; Health Maintenance Organizations; Health Services; Humans; Male; Mass Screening; Middle Aged; Patient Education as Topic; Primary Health Care; Psychiatric Status Rating Scales; Sertraline | 2000 |
Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life.
Topics: Age Factors; Age of Onset; Aged; Ambulatory Care; Antidepressive Agents, Tricyclic; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nortriptyline; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 2000 |
Four-year follow-up study of sertraline and fluvoxamine in long-term treatment of unipolar subjects with high recurrence rate.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Fluvoxamine; Follow-Up Studies; Humans; Male; Middle Aged; Recurrence; Sertraline; Treatment Outcome | 2000 |
Heuristic comparison of sertraline with nortriptyline for the treatment of depression in frail elderly patients.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Frail Elderly; Homes for the Aged; Humans; Male; Nortriptyline; Nursing Homes; Sertraline; Treatment Outcome | 2000 |
Lost human capital from early-onset chronic depression.
Topics: Adult; Age of Onset; Aged; Censuses; Chronic Disease; Cost of Illness; Depressive Disorder; Double-Blind Method; Educational Status; Female; Humans; Imipramine; Income; Male; Middle Aged; Outcome Assessment, Health Care; Regression Analysis; Sertraline; Sex Factors; Treatment Outcome; United States | 2000 |
Platelet activation in depression and effects of sertraline treatment: An open-label study.
Topics: Adult; Blood Platelets; Collagen; Depressive Disorder; Female; Humans; Male; Middle Aged; Platelet Activation; Platelet Glycoprotein GPIIb-IIIa Complex; Psychiatric Status Rating Scales; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2000 |
Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2000 |
The effect of sertraline on methadone plasma levels in methadone-maintenance patients.
Topics: Adult; Depressive Disorder; Double-Blind Method; Drug Interactions; Female; Humans; Male; Methadone; Narcotics; Opioid-Related Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline | 2000 |
Gender differences in treatment response to sertraline versus imipramine in chronic depression.
Topics: Adult; Aged; Ambulatory Care; Antidepressive Agents, Tricyclic; Chronic Disease; Depressive Disorder; Double-Blind Method; Dysthymic Disorder; Estrogens; Female; Humans; Imipramine; Male; Middle Aged; Patient Dropouts; Placebos; Premenopause; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Sex Factors; Treatment Outcome | 2000 |
Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults. The Australian and German Study Groups.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Humans; Libido; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Surveys and Questionnaires; Time Factors | 2000 |
Will a second prophylactic treatment with a higher dosage of the same antidepressant either prevent or delay new depressive episodes?
Topics: Adult; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Proportional Hazards Models; Risk Factors; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 2000 |
A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients.
Topics: Age Factors; Aged; Ambulatory Care; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2000 |
Predictors of response to sertraline treatment of severe premenstrual syndromes.
Topics: Adolescent; Adult; Depressive Disorder; Double-Blind Method; Female; Humans; Middle Aged; Multivariate Analysis; Placebos; Premenstrual Syndrome; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method; Treatment Outcome | 2000 |
A double-blind study of the efficacy and safety of sertraline and clomipramine in outpatients with severe major depression.
Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Outpatients; Sertraline; Severity of Illness Index; Sleep; Treatment Outcome | 2000 |
Non-compliance with pharmacotherapy of depression is associated with a sensation seeking personality.
Topics: Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder; Double-Blind Method; Female; Humans; Impulsive Behavior; Male; Middle Aged; Patient Compliance; Personality; Personality Assessment; Sertraline | 2000 |
Sertraline in the treatment of major depression following mild traumatic brain injury.
Topics: Adult; Antidepressive Agents, Second-Generation; Brain Concussion; Depressive Disorder; Female; Health Status Indicators; Humans; Male; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sickness Impact Profile | 2000 |
Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the Depression in Alzheimer's Disease study.
Topics: Aged; Alzheimer Disease; Ambulatory Care; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2000 |
Regional cerebral blood flow in mood disorders, V.: Effects of antidepressant medication in late-life depression.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Antidepressive Agents; Brain; Brain Mapping; Cerebrovascular Circulation; Depressive Disorder; Female; Humans; Male; Middle Aged; Nortriptyline; Sertraline; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Xenon Radioisotopes | 2000 |
Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline.
Topics: Adult; Citalopram; Depressive Disorder; Double-Blind Method; Electrocardiography; Endpoint Determination; Female; Humans; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Treatment Outcome | 2000 |
Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.
Topics: Adolescent; Adult; Aged; Comorbidity; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2000 |
Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment.
Topics: Adult; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Humans; Longitudinal Studies; Male; Middle Aged; Paroxetine; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain | 2000 |
The efficacy of sertraline in panic disorder: combined results from two fixed-dose studies.
Topics: Adolescent; Adult; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Panic Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method | 2000 |
Are there differences by gender in response to pharmacotherapy for depression?
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Antidepressive Agents, Tricyclic; Chi-Square Distribution; Confounding Factors, Epidemiologic; Depressive Disorder; Dysthymic Disorder; Female; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Patient Compliance; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Treatment Outcome | 2000 |
Efficacy and response time to sertraline versus fluoxetine in the treatment of unipolar major depressive disorder.
Topics: Adult; Ambulatory Care; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method; Treatment Outcome | 2000 |
Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Incidence; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Recurrence; Sertraline; Sexual Dysfunctions, Psychological; Treatment Outcome; Triazoles | 2001 |
Serotonergic function in major depression and effect of sertraline and paroxetine treatment.
Topics: Administration, Oral; Adult; Depressive Disorder; Female; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Paroxetine; Recurrence; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Sertraline; Treatment Outcome | 2001 |
Double-blind clinical trial of sertraline treatment for alcohol dependence.
Topics: Adult; Alcoholism; Analysis of Variance; Chi-Square Distribution; Depressive Disorder; Diagnosis, Dual (Psychiatry); Double-Blind Method; Female; Humans; Male; Middle Aged; Prospective Studies; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline | 2001 |
An open, baseline controlled evaluation of sertraline safety and efficacy in the treatment of depression in Thai patients.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Male; Middle Aged; Patient Compliance; Sertraline; Severity of Illness Index; Thailand; Treatment Outcome | 2001 |
Clinical and treatment response characteristics of late-life depression associated with vascular disease: a pooled analysis of two multicenter trials with sertraline.
Topics: Age of Onset; Aged; Antidepressive Agents; Anxiety; Cardiovascular Diseases; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Hypertension; Male; Mental Status Schedule; Middle Aged; Nortriptyline; Patient Selection; Placebos; Psychiatric Status Rating Scales; Safety; Sertraline; Vascular Diseases | 2001 |
Sertraline effects in adolescent major depression and dysthymia: a six-month open trial.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Depressive Disorder; Dysthymic Disorder; Female; Humans; Male; Psychiatric Status Rating Scales; Sertraline | 2001 |
Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction.
Topics: Acute Disease; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Heart; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Sympathetic Nervous System; Treatment Outcome | 2001 |
Faster response on amisulpride 50 mg versus sertraline 50-100 mg in patients with dysthymia or double depression: a randomized, double-blind, parallel group study.
Topics: Adolescent; Adult; Aged; Amisulpride; Antidepressive Agents; Antipsychotic Agents; Depressive Disorder; Double-Blind Method; Dysthymic Disorder; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline; Sulpiride | 2001 |
Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Family Practice; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2001 |
Improvement in activities of daily living in elderly following treatment for post-bereavement depression.
Topics: Activities of Daily Living; Aged; Antidepressive Agents; Bereavement; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Nortriptyline; Pilot Projects; Psychiatric Status Rating Scales; Sertraline; Treatment Outcome | 2002 |
Managing depression in brain injury rehabilitation: the use of an integrated care pathway and preliminary report of response to sertraline.
Topics: Adolescent; Adult; Antidepressive Agents; Brain Injuries; Critical Pathways; Depressive Disorder; Female; Humans; Male; Middle Aged; Prospective Studies; Sertraline; Stroke; Stroke Rehabilitation | 2002 |
Efficacy of continuation treatment with hypericum perforatum in depression.
Topics: Depressive Disorder; Double-Blind Method; Follow-Up Studies; Humans; Hypericum; Phytotherapy; Plant Extracts; Psychiatric Status Rating Scales; Secondary Prevention; Sertraline; Treatment Outcome | 2002 |
St John's wort or sertraline? Randomized controlled trial in primary care.
Topics: Adult; Analysis of Variance; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Humans; Hypericum; Male; Middle Aged; Phytotherapy; Plant Extracts; Sertraline | 2002 |
Are patients who are intolerant to one SSRI intolerant to another?
Topics: 1-Naphthylamine; Adult; Aged; Depressive Disorder; Drug Tolerance; Female; Fluoxetine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method | 1992 |
Bridging the gap between psychiatric practice and primary care.
Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Dothiepin; Double-Blind Method; Female; Humans; Male; Middle Aged; Patient Care Team; Personality Inventory; Primary Health Care; Selective Serotonin Reuptake Inhibitors; Sertraline | 1992 |
Sertraline in the prevention of depression.
Topics: 1-Naphthylamine; Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Sertraline; Suicide, Attempted | 1992 |
Controlling acute episodes of depression.
Topics: 1-Naphthylamine; Acute Disease; Aged; Amitriptyline; Antidepressive Agents; Bipolar Disorder; Depressive Disorder; Double-Blind Method; Humans; Personality Tests; Sertraline | 1991 |
Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression.
Topics: 1-Naphthylamine; Adolescent; Adult; Aged; Ambulatory Care; Amitriptyline; Depressive Disorder; Dizziness; Double-Blind Method; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Serotonin Antagonists; Sertraline; Sexual Dysfunctions, Psychological | 1990 |
Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients.
Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Amitriptyline; Body Weight; Depressive Disorder; Drug Therapy, Combination; Female; Heart Rate; Humans; Male; Personality Inventory; Psychiatric Status Rating Scales; Pulse; Serotonin Antagonists; Sertraline | 1990 |
Sertraline: a new antidepressant.
Topics: 1-Naphthylamine; Amitriptyline; Animals; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Male; Mice; Naphthalenes; Rats; Receptors, Adrenergic, beta; Receptors, Neurotransmitter; Serotonin Antagonists; Sertraline | 1988 |
Acute effects of sertraline, amitriptyline, and placebo on the psychomotor performance of healthy subjects over 50 years of age.
Topics: 1-Naphthylamine; Administration, Oral; Age Factors; Aged; Amitriptyline; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Naphthalenes; Placebos; Psychomotor Performance; Serotonin Antagonists; Sertraline | 1988 |
Sertraline, a selective inhibitor of serotonin uptake, for the treatment of outpatients with major depressive disorder.
Topics: 1-Naphthylamine; Adult; Aged; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Naphthalenes; Outpatients; Random Allocation; Serotonin Antagonists; Sertraline | 1988 |
Computerized EEG correlates of depression and antidepressant treatment.
Topics: 1-Naphthylamine; Adult; Amitriptyline; Clinical Trials as Topic; Computers; Depressive Disorder; Double-Blind Method; Electroencephalography; Evoked Potentials; Female; Humans; Male; Naphthalenes; Serotonin Antagonists; Sertraline | 1987 |
The dexamethasone suppression test and response to placebo.
Topics: 1-Naphthylamine; Clinical Trials as Topic; Depressive Disorder; Dexamethasone; Double-Blind Method; Humans; Maprotiline; Placebos; Sertraline | 1986 |
283 other study(ies) available for sertraline and Depression, Endogenous
| Article | Year |
|---|---|
[Successful psychopharmacotherapy of anxiety and depressive disorders improve functional limitations in patients with rheumatoid arthritis].
Topics: Antirheumatic Agents; Anxiety; Arthritis, Rheumatoid; Biological Products; Depression; Depressive Disorder; Female; Humans; Male; Middle Aged; Sertraline; Severity of Illness Index | 2022 |
IV Lidocaine Infusion Leading to the Toxic Levels in Serum Causing Asystole - A Case Report.
Topics: Anesthetics; Depressive Disorder; Drug Interactions; Female; Headache Disorders; Heart Arrest; Humans; Infusions, Intravenous; Lidocaine; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Trazodone | 2020 |
The long and winding road of discontinuing long-term use of antidepressants: Learning from my experience.
Topics: Adult; Depressive Disorder; Female; Humans; Practice Guidelines as Topic; Professional-Patient Relations; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome; United Kingdom | 2020 |
[The power plants of the cell: Treatment of psychiatric symptoms in patients with mitochondriopathy].
Topics: Depressive Disorder; Female; Humans; Mitochondrial Diseases; Neuropsychological Tests; Panic Disorder; Personality; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Young Adult | 2017 |
Pseudocyesis: Birth of a Phantom.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Female; Humans; Pseudopregnancy; Sertraline; Suicide, Attempted | 2017 |
Neuroleptic malignant syndrome (NMS) associated with amisulpride and sertraline use: A case report and discussion.
Topics: Aged; Amisulpride; Antipsychotic Agents; Depressive Disorder; Female; Humans; Neuroleptic Malignant Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline | 2019 |
Sertraline-induced Hemichorea.
Topics: Aged; Chorea; Depressive Disorder; Diagnosis, Differential; Dyskinesia, Drug-Induced; Dyskinesias; Female; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline | 2017 |
Trends and Patterns of Antidepressant Use in French Children and Adolescents From 2009 to 2016: A Population-Based Study in the French Health Insurance Database.
Topics: Adolescent; Age Factors; Amitriptyline; Antidepressive Agents; Antidepressive Agents, Tricyclic; Child; Databases, Factual; Depressive Disorder; Female; France; Humans; Incidence; Insurance, Health; Male; Off-Label Use; Practice Patterns, Physicians'; Prevalence; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors | 2018 |
Lack of rapid antidepressant effects of Kir4.1 channel inhibitors in a chronic social defeat stress model: Comparison with (R)-ketamine.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Depressive Disorder; Disease Models, Animal; Hippocampus; Ketamine; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Potassium Channels, Inwardly Rectifying; Quinacrine; Sertraline; Stress, Psychological | 2019 |
Developmental outcomes after gestational antidepressant treatment with sertraline and its discontinuation in an animal model of maternal depression.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Corticosterone; Depression; Depressive Disorder; Disease Models, Animal; Exploratory Behavior; Female; Male; Maternal Behavior; Postpartum Period; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Stress, Psychological | 2019 |
Treatment of Depression Versus Treatment of PTSD.
Topics: Depression; Depressive Disorder; Humans; Sertraline; Stress Disorders, Post-Traumatic | 2019 |
Effects of SSRIs on peripheral inflammatory cytokines in patients with Generalized Anxiety Disorder.
Topics: Adult; Aged; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Anxiety Disorders; C-Reactive Protein; Citalopram; Cohort Studies; Cytokines; Depression; Depressive Disorder; Female; Humans; Interleukin-12; Interleukin-6; Male; Middle Aged; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 2019 |
A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline.
Topics: Acetamides; Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder; Depressive Disorder, Major; Female; Fluoxetine; Humans; Hypnotics and Sedatives; Male; Middle Aged; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Sertraline; Treatment Outcome; Young Adult | 2013 |
Integrative medicine. Depression.
Topics: Adult; Combined Modality Therapy; Depressive Disorder; Dietary Supplements; Exercise; Fatty Acids, Omega-3; Female; Humans; Integrative Medicine; Mind-Body Therapies; S-Adenosylmethionine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2013 |
Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg.
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Citalopram; Depressive Disorder; Female; Heart Diseases; Humans; Male; Middle Aged; Mortality; Proportional Hazards Models; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; United States; United States Food and Drug Administration | 2013 |
Different serum BDNF levels in depression: results from BDNF studies in FYR Macedonia and Bulgaria.
Topics: Adult; Aged; Brain-Derived Neurotrophic Factor; Bulgaria; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Republic of North Macedonia; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2013 |
Hypercalcemia and PHPT presenting with mental health crisis - a case report.
Topics: Antidepressive Agents; Depressive Disorder; Diagnosis, Differential; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Male; Mental Health; Middle Aged; Psychotherapy; Sertraline | 2013 |
Sertraline-induced acneiform eruption.
Topics: Acneiform Eruptions; Adult; Antidepressive Agents; Depressive Disorder; Female; Humans; Sertraline | 2014 |
Antidepressant-like effect of n-3 PUFAs in CUMS rats: role of tPA/PAI-1 system.
Topics: Animals; Antidepressive Agents; Body Weight; Brain-Derived Neurotrophic Factor; Chronic Disease; Depressive Disorder; Disease Models, Animal; Fatty Acids, Omega-3; Hippocampus; Plasminogen Activator Inhibitor 1; Prefrontal Cortex; Random Allocation; Rats, Sprague-Dawley; Sertraline; Stress, Psychological; Tissue Plasminogen Activator | 2015 |
Effects of long-term sertraline treatment and depression on coronary artery atherosclerosis in premenopausal female primates.
Topics: Animals; Atherosclerosis; Behavior, Animal; Coronary Artery Disease; Coronary Vessels; Depressive Disorder; Disease Models, Animal; Female; Iliac Artery; Longitudinal Studies; Macaca fascicularis; Premenopause; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline | 2015 |
Long term sertraline effects on neural structures in depressed and nondepressed adult female nonhuman primates.
Topics: Administration, Oral; Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Brain; Depressive Disorder; Female; Hydroxyindoleacetic Acid; Macaca fascicularis; Magnetic Resonance Imaging; Organ Size; Random Allocation; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2015 |
Clinically Useful Genetic Markers of Antidepressant Response: How Do We Get There From Here?
Topics: Antidepressive Agents; Anxiety; Citalopram; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Male; Sertraline | 2015 |
The girl who would not sit--case report.
Topics: Culture; Depressive Disorder; Ethnicity; Fear; Female; Housing; Humans; Obsessive-Compulsive Disorder; Psychotherapy; Sertraline; Social Isolation; Social Stigma; Social Values; United Kingdom; Young Adult | 2015 |
Studies regarding the protective effects exhibited by antidepressants on cell models.
Topics: Antidepressive Agents; Antioxidants; Cell Membrane; Depressive Disorder; Dose-Response Relationship, Drug; Erythrocytes; Female; Fluoxetine; Glucosephosphate Dehydrogenase; Humans; Immune System; Lipid Peroxidation; Middle Aged; Oxidative Stress; Sertraline; U937 Cells; Venlafaxine Hydrochloride | 2015 |
Effect of co-administration of memantine and sertraline on the antidepressant-like activity and brain-derived neurotrophic factor (BDNF) levels in the rat brain.
Topics: Animals; Antidepressive Agents; Brain; Brain-Derived Neurotrophic Factor; Depressive Disorder; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Male; Memantine; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Sertraline | 2017 |
[Development of cerebral infarcts in a 17-year-old male treated with sertraline and lisdexamfetamine].
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cerebral Infarction; Depressive Disorder; Diffusion Magnetic Resonance Imaging; Humans; Lisdexamfetamine Dimesylate; Male; Selective Serotonin Reuptake Inhibitors; Sertraline | 2016 |
[Rhabdomyolysis after lifting IKEA bags in a man using sertraline].
Topics: Adult; Antidepressive Agents; Depressive Disorder; Humans; Lifting; Male; Rhabdomyolysis; Sertraline | 2016 |
Sertraline in pregnancy - Therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood.
Topics: Adult; Amniotic Fluid; Depressive Disorder; Drug Monitoring; Female; Fetal Blood; Humans; Placenta; Pregnancy; Pregnancy Complications; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 2017 |
Rectal Bioavailability of Sertraline Tablets in a Critically Ill Patient With Bowel Compromise.
Topics: Antidepressive Agents; Anxiety Disorders; Biological Availability; Critical Illness; Depressive Disorder; Female; Humans; Intestines; Middle Aged; Sertraline | 2017 |
Recurrent relapses of depression in a patient established on sertraline after taking herbal medicinal mixtures--a herb-drug interaction?
Topics: Commiphora; Depressive Disorder; Female; Herb-Drug Interactions; Humans; Middle Aged; Phytotherapy; Plant Extracts; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Terminalia | 2009 |
Unraveling depression in Parkinson's disease.
Topics: Antidepressive Agents; Benzothiazoles; Clinical Trials as Topic; Cohort Studies; Depression; Depressive Disorder; Dopamine; Dopamine Agonists; Drug Interactions; Humans; Multicenter Studies as Topic; Parkinson Disease; Pramipexole; Quality of Life; Serotonin; Sertraline | 2008 |
Frontal white matter anisotropy and antidepressant remission in late-life depression.
Topics: Aged; Aged, 80 and over; Aging; Anisotropy; Antidepressive Agents; Brain; Brain Mapping; Depressive Disorder; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Remission Induction; Sertraline | 2008 |
Unusual weight fluctuation under corticosteroid and psychotropic treatment.
Topics: Adult; Anti-Inflammatory Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Appetite; Aripiprazole; Body Weight; Cyclosporine; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Eating; Female; Humans; Mianserin; Paroxetine; Piperazines; Prednisolone; Quinolones; Sertraline; Takayasu Arteritis | 2008 |
Recent NIMH clinical trials and implications for practice.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Child, Preschool; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Fluoxetine; Humans; Mental Disorders; Methylphenidate; Multicenter Studies as Topic; National Institute of Mental Health (U.S.); Obsessive-Compulsive Disorder; Psychotropic Drugs; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States; Venlafaxine Hydrochloride | 2008 |
Nonverbal communication sets the conditions for the relationship between parental bonding and the short-term treatment response in depression.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Dysthymic Disorder; Female; Humans; Interview, Psychological; Male; Middle Aged; Nonverbal Communication; Object Attachment; Parent-Child Relations; Parenting; Personality Inventory; Prognosis; Recurrence; Sertraline; Treatment Outcome; Young Adult | 2009 |
Preliminary evidence that a functional polymorphism in type 1 deiodinase is associated with enhanced potentiation of the antidepressant effect of sertraline by triiodothyronine.
Topics: Antidepressive Agents; Depressive Disorder; DNA; Drug Therapy, Combination; Genotype; Humans; Iodide Peroxidase; Iodothyronine Deiodinase Type II; Polymorphism, Single Nucleotide; Psychiatric Status Rating Scales; Sertraline; Thyroid Function Tests; Thyrotropin; Triiodothyronine | 2009 |
Sertraline-induced photoallergic reaction.
Topics: Aged; Antidepressive Agents; Depressive Disorder; Dermatitis, Photoallergic; Erythema; Female; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline | 2009 |
Antidepressant switching among adherent patients treated for depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Drug Administration Schedule; Humans; Mianserin; Middle Aged; Mirtazapine; Patient Compliance; Sertraline; Trazodone; Venlafaxine Hydrochloride; Young Adult | 2009 |
Muscle sympathetic nervous activity in depressed patients before and after treatment with sertraline.
Topics: Adolescent; Adult; Blood Pressure; Cardiotonic Agents; Cognition; Depressive Disorder; Electrophysiology; Female; Humans; Male; Microelectrodes; Middle Aged; Muscle, Skeletal; Peroneal Nerve; Psychological Tests; Regional Blood Flow; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress, Psychological; Sympathetic Nervous System; Young Adult | 2009 |
Sertraline improves executive function in patients with vascular cognitive impairment.
Topics: Aged; Aged, 80 and over; Dementia, Vascular; Depressive Disorder; Drug Administration Schedule; Executive Function; Humans; Male; Middle Aged; Neuropsychological Tests; Off-Label Use; Patient Selection; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Statistics, Nonparametric | 2009 |
Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts.
Topics: Adolescent; Antidepressive Agents; Child; Citalopram; Cohort Studies; Cross-Sectional Studies; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide; Suicide Prevention; Suicide, Attempted | 2010 |
Rapid and sustained response to a single dose of sertraline in a patient with newly emergent depression during varenicline-assisted smoking cessation.
Topics: Adult; Antidepressive Agents; Benzazepines; Depressive Disorder; Humans; Male; Quinoxalines; Sertraline; Smoking Cessation; Varenicline | 2010 |
Affective and anxiety disorders: prevalence, treatment and antidepressant medication use.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antidepressive Agents; Anxiety Disorders; Australia; Citalopram; Cross-Sectional Studies; Depressive Disorder; Drug Utilization; Female; Health Surveys; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Statistical Distributions; Young Adult | 2010 |
An audit to compare discharge rates between antidepressant monotherapies prescribed for pure unipolar depression versus depression in the presence of other indications.
Topics: Adult; Antidepressive Agents; Citalopram; Community Mental Health Centers; Comorbidity; Cyclohexanols; Depressive Disorder; England; Fluoxetine; Guideline Adherence; Humans; Medical Audit; Mianserin; Mirtazapine; Patient Discharge; Practice Patterns, Physicians'; Sertraline; Suicide; Suicide Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
An audit to compare discharge rates and suicidality between antidepressant monotherapies prescribed for unipolar depression.
Topics: Adult; Antidepressive Agents; Citalopram; Community Mental Health Centers; Cyclohexanols; Depressive Disorder; England; Humans; Medical Audit; Mianserin; Mirtazapine; Patient Discharge; Sertraline; Suicide; Suicide Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Menorrhagia and ecchymoses in an adolescent girl treated with sertaline.
Topics: Adolescent; Anxiety Disorders; Depressive Disorder; Drug Substitution; Ecchymosis; Female; Humans; Menorrhagia; Selective Serotonin Reuptake Inhibitors; Sertraline | 2010 |
[Torin (sertraline) in the treatment of depressive and obsessive-compulsive disorders in children].
Topics: Antidepressive Agents; Child; Depressive Disorder; Female; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline | 2010 |
Understanding factors associated with early therapeutic alliance in PTSD treatment: adherence, childhood sexual abuse history, and social support.
Topics: Adolescent; Adult; Adult Survivors of Child Abuse; Aged; Child; Child Abuse, Sexual; Depressive Disorder; Female; Humans; Implosive Therapy; Life Change Events; Male; Middle Aged; Patient Compliance; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Support; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Treatment Outcome | 2010 |
Was Cipriani right? Audits to compare discharge rates and suicidality between antidepressant monotherapies used in a British community mental health team.
Topics: Antidepressive Agents; Citalopram; Community Mental Health Services; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Humans; Medical Audit; Mianserin; Mirtazapine; Outcome Assessment, Health Care; Patient Discharge; Sertraline; Suicidal Ideation; Suicide; Suicide Prevention; Treatment Outcome; United Kingdom; Venlafaxine Hydrochloride | 2010 |
Promoting adherence to psychotropic medication for youth-part 2.
Topics: Adolescent; Antidepressive Agents; Behavior Therapy; Contracts; Depressive Disorder; Health Knowledge, Attitudes, Practice; Humans; Medication Adherence; Parenting; Patient Education as Topic; Psychiatric Nursing; Psychotropic Drugs; Sertraline | 2010 |
The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients.
Topics: Adult; Aged; Asian People; Biomarkers; Brain-Derived Neurotrophic Factor; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Heterozygote; Humans; Logistic Models; Male; Middle Aged; Paroxetine; Polymorphism, Genetic; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult | 2011 |
Collaborative care for depression and chronic illnesses.
Topics: Antidepressive Agents; Chronic Disease; Cost-Benefit Analysis; Depressive Disorder; Diabetes Mellitus; Glycated Hemoglobin; Humans; Physicians, Primary Care; Randomized Controlled Trials as Topic; Sertraline | 2011 |
Treatment of depressive-like behaviour in Huntington's disease mice by chronic sertraline and exercise.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Cell Proliferation; Depressive Disorder; Disease Models, Animal; Female; Gene Expression; Hippocampus; Huntington Disease; Mice; Mice, Transgenic; Physical Conditioning, Animal; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Agonists; Sertraline; Swimming | 2012 |
Antidepressant treatment in Alzheimer's disease.
Topics: Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Dementia; Depressive Disorder; Double-Blind Method; Humans; Mianserin; Mirtazapine; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Sertraline | 2011 |
Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression?
Topics: Adult; Bias; Bupropion; Buspirone; Cluster Analysis; Cyclohexanols; Depressive Disorder; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sertraline; Treatment Failure; Treatment Outcome; Venlafaxine Hydrochloride | 2011 |
The MMPI-2 neurotic triad subscales and depression levels after pharmacological treatment in patients with depressive disorders - clinical study.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Female; Fluoxetine; Humans; Hypochondriasis; Hysteria; Male; Middle Aged; MMPI; Neurotic Disorders; Observer Variation; Paroxetine; Psychometrics; Reproducibility of Results; Sertraline; Statistics as Topic; Young Adult | 2011 |
Stay the course--is it justified?
Topics: Alzheimer Disease; Antidepressive Agents; Dementia; Depressive Disorder; Female; Humans; Male; Mental Disorders; Mianserin; Sertraline | 2012 |
High venlafaxine serum levels after prior fluoxetine medication.
Topics: Antidepressive Agents, Second-Generation; Cholinergic Antagonists; Cyclohexanols; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder; Female; Fluoxetine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2012 |
Sertraline-induced hyponatremia and seizures in old age.
Topics: Antidepressive Agents; Depressive Disorder; Humans; Hyponatremia; Male; Middle Aged; Seizures; Sertraline | 2012 |
Selective serotonin reuptake inhibitors and persistent pulmonary hypertension of the newborn.
Topics: Adult; Depressive Disorder; Evidence-Based Medicine; Female; Humans; Infant, Newborn; Patient Education as Topic; Persistent Fetal Circulation Syndrome; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Sertraline | 2012 |
[Use of pregabalin and sertraline in complex treatment of patients with partial epilepsy comorbid with depressive and anxiety disorders].
Topics: Adult; Anticonvulsants; Antidepressive Agents; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Epilepsies, Partial; Female; gamma-Aminobutyric Acid; Humans; Male; Pregabalin; Sertraline; Treatment Outcome | 2012 |
Serotonergic overstimulation in a preterm infant after sertraline intake via breastmilk.
Topics: Adult; Antidepressive Agents; Blood-Brain Barrier; Depressive Disorder; Female; Humans; Infant Formula; Infant, Newborn; Infant, Premature; Male; Milk, Human; Mothers; Pregnancy; Selective Serotonin Reuptake Inhibitors; Sertraline; Tremor | 2013 |
[Treatment of comorbid obsessive-compulsive and depressive disorders in children age].
Topics: Adolescent; Antidepressive Agents; Child; Comorbidity; Depressive Disorder; Female; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Psychometrics; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2012 |
[The comparative study on the efficacy of the combination of serotonin reuptake inhibitor antidepressants and antipsychotics in the treatment of recurrent depressive disorders].
Topics: Adolescent; Adult; Amisulpride; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Olanzapine; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Sulpiride; Treatment Outcome; Young Adult | 2012 |
Economic evaluation of St. John's wort (Hypericum perforatum) for the treatment of mild to moderate depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Australia; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder; Depressive Disorder, Major; Humans; Hypericum; Markov Chains; Middle Aged; Models, Economic; Phytotherapy; Plant Preparations; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2013 |
Neural correlates of treatment response in depressed bipolar adolescents during emotion processing.
Topics: Adolescent; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Brain; Citalopram; Depressive Disorder; Dibenzothiazepines; Drug Therapy, Combination; Emotions; Facial Expression; Female; Humans; Lamotrigine; Magnetic Resonance Imaging; Male; Piperazines; Psychotropic Drugs; Quetiapine Fumarate; Quinolones; Sertraline; Triazines; Valproic Acid | 2013 |
[Stabilizing affective symptoms without adverse cardiac effects. Myocardial infarct risk after depression--and vice versa].
Topics: Affect; Antidepressive Agents; Depressive Disorder; Heart Rate; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Sertraline; Treatment Outcome | 2002 |
[Sertraline in the treatment of post-stroke depression--results of an open multicenter study].
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Personality Assessment; Quality of Life; Sertraline; Stroke; Stroke Rehabilitation; Treatment Outcome | 2002 |
Don't ignore heart-attack blues.
Topics: Antidepressive Agents; Coronary Disease; Depressive Disorder; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Moclobemide discontinuation syndrome predominantly presenting with influenza-like symptoms.
Topics: Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Influenza, Human; Long-Term Care; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome | 2002 |
[Rapid treatment effect. An effective antidepressant dissolves on the tongue].
Topics: Administration, Oral; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive Disorder; Drug Administration Schedule; Humans; Mianserin; Mirtazapine; Sertraline; Treatment Outcome | 2002 |
Sertraline-induced akathisia and dystonia misinterpreted as a panic attack.
Topics: Adult; Akathisia, Drug-Induced; Depressive Disorder; Diagnosis, Differential; Dystonia; Humans; Male; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Sertraline for treatment of depression in acute coronary syndromes.
Topics: Angina, Unstable; Antidepressive Agents; Depressive Disorder; Humans; Myocardial Infarction; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Ventricular Function, Left | 2002 |
Sertraline for treatment of depression in acute coronary syndromes.
Topics: Angina, Unstable; Antidepressive Agents; Depressive Disorder; Humans; Myocardial Infarction; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Ventricular Function, Left | 2002 |
The antidepressant debate continues.
Topics: Antidepressive Agents; Counseling; Depressive Disorder; Family Practice; Humans; Mianserin; Sertraline | 2002 |
Adverse events in users of sertraline: results from an observational study in psychiatric practice in The Netherlands.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anxiety Disorders; Child; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Netherlands; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
The pharmacokinetics of sertraline excretion into human breast milk: determinants of infant serum concentrations.
Topics: Breast Feeding; Child Development; Chromatography, High Pressure Liquid; Depressive Disorder; Female; Humans; Infant, Newborn; Lactation; Milk, Human; Pregnancy; Selective Serotonin Reuptake Inhibitors; Sertraline | 2003 |
Selective serotonin reuptake inhibitor usage patterns as risk factors for hospitalization.
Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Utilization Review; Fluoxetine; Health Maintenance Organizations; Hospitalization; Humans; Medical Audit; Midwestern United States; Paroxetine; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Is left stroke a risk-factor for selective serotonin reuptake inhibitor antidepressant treatment resistance?
Topics: Administration, Oral; Aged; Cognition; Depressive Disorder; Drug Resistance; Female; Fluoxetine; Functional Laterality; Humans; Male; Middle Aged; Prognosis; Psychiatric Status Rating Scales; Psychometrics; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Stroke | 2003 |
Burning mouth syndrome as a side effect of SSRIs.
Topics: Burning Mouth Syndrome; Citalopram; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2003 |
Placental passage of antidepressant medications.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fetal Blood; Fluoxetine; Humans; Maternal-Fetal Exchange; Paroxetine; Placenta; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Sertraline | 2003 |
Prophylaxis of depression in older people.
Topics: Aged; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Humans; Randomized Controlled Trials as Topic; Recurrence; Sertraline | 2003 |
[Always tired and unconcentrated at work. Assessing the patient for possible depression].
Topics: Antidepressive Agents; Attention; Depressive Disorder; Diagnosis, Differential; Fatigue; Humans; Occupational Diseases; Sertraline | 2003 |
Changes in energy after switching from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine.
Topics: Citalopram; Depressive Disorder; Drug Administration Schedule; Fatigue; Fluoxetine; Humans; Paroxetine; Quality of Life; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 2004 |
The positive side: for some children, antidepressants make the difference.
Topics: Child; Combined Modality Therapy; Depressive Disorder; Female; Humans; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Sertraline | 2004 |
Ssri-induced sexual dysfunction in adolescents.
Topics: Adolescent; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Cross-Sectional Studies; Depressive Disorder; Female; Hospitals, University; Humans; Male; Psychiatric Department, Hospital; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological | 2004 |
Itch and skin rash from chocolate during fluoxetine and sertraline treatment: case report.
Topics: Cacao; Depressive Disorder; Exanthema; Fluoxetine; Humans; Male; Middle Aged; Pruritus; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline | 2004 |
Neurobiology of decreased heart rate variability in older patients with recent acute coronary syndrome.
Topics: Aged; Aging; Arrhythmias, Cardiac; Depressive Disorder; Heart Rate; Humans; Middle Aged; Myocardial Infarction; Selective Serotonin Reuptake Inhibitors; Sertraline | 2004 |
Gender differences in routine treatment of depressed outpatients with the selective serotonin reuptake inhibitor sertraline.
Topics: Adult; Aged; Depressive Disorder; Drug Utilization Review; Female; Humans; Male; Middle Aged; Outpatients; Practice Patterns, Physicians'; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Sex Factors | 2005 |
Validation of the Bech-Rafaelsen Melancholia Scale and the Hamilton Depression Scale in patients with major depression; is the total score a valid measure of illness severity?
Topics: Adolescent; Adult; Aged; Depressive Disorder; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Male; Middle Aged; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Surveys and Questionnaires | 2005 |
Sertraline and venlafaxine: new indication. Prevention of recurrent depression: no advance.
Topics: Antidepressive Agents; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Double-Blind Method; Drug Approval; France; Humans; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2005 |
Quality-of-life impairment in depressive and anxiety disorders.
Topics: Adult; Anxiety Disorders; Comorbidity; Depressive Disorder; Female; Humans; Male; Personal Satisfaction; Quality of Life; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires | 2005 |
Agitated dysphoria after late-onset loss of response to antidepressants: a case report.
Topics: Akathisia, Drug-Induced; Anticonvulsants; Antidepressive Agents; Bipolar Disorder; Combined Modality Therapy; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Lithium Carbonate; Middle Aged; Psychotherapy; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2005 |
Hallucinogen persisting perception disorder after psilocybin consumption: a case study.
Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Anxiety; Depressive Disorder; Diagnosis, Differential; Hallucinogens; Humans; Male; Marijuana Smoking; Perceptual Disorders; Psilocybin; Psychiatric Status Rating Scales; Recurrence; Risperidone; Sertraline; Social Behavior Disorders; Time Factors | 2005 |
Pseudohallucinations associated with moclobemide: a case report.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Hallucinations; Humans; Male; Mianserin; Mirtazapine; Moclobemide; Monoamine Oxidase Inhibitors; Sertraline | 2005 |
Dextromethorphan-induced delirium and possible methadone interaction.
Topics: Aged; Analgesics, Opioid; Antitussive Agents; Cough; Delirium; Depressive Disorder; Dextromethorphan; Drug Interactions; Female; Humans; Methadone; Pain; Selective Serotonin Reuptake Inhibitors; Sertraline | 2005 |
Serotonin syndrome: a case report.
Topics: Child; Depressive Disorder; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline | 2005 |
Biochemical profile in patients with anxious depression under the treatment with serotonergic antidepressants with different mechanisms of action.
Topics: Adolescent; Adult; Amine Oxidase (Copper-Containing); Antidepressive Agents; Anxiety Disorders; Depressive Disorder; Female; Humans; Male; Middle Aged; Monoamine Oxidase; Selective Serotonin Reuptake Inhibitors; Sertraline; Serum Albumin; Thiazepines | 2006 |
Depression in older adults: the case of an 82-year-old woman with dizziness.
Topics: Aged, 80 and over; Depressive Disorder; Dizziness; Female; Humans; Psychological Tests; Selective Serotonin Reuptake Inhibitors; Sertraline | 2006 |
Drug interactions between linezolid and selective serotonin reuptake inhibitors: case report involving sertraline and review of the literature.
Topics: Acetamides; Amputation Stumps; Anti-Bacterial Agents; Depressive Disorder; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Interactions; Fatal Outcome; Female; Gangrene; Humans; Linezolid; Middle Aged; Neurotoxicity Syndromes; Oxazolidinones; Selective Serotonin Reuptake Inhibitors; Sertraline; Surgical Wound Infection | 2006 |
Quetiapine plus SSRI in treatment-resistant depression: possible mechanisms.
Topics: Adult; Antipsychotic Agents; Depressive Disorder; Dibenzothiazepines; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Sertraline | 2006 |
Persistent sexual side effects after SSRI discontinuation.
Topics: Adult; Androgens; Anxiety; Bupropion; Cabergoline; Citalopram; Depressive Disorder; Dopamine Agonists; Dopamine Uptake Inhibitors; Ergolines; Female; Fluoxetine; Humans; Male; Monoamine Oxidase Inhibitors; Piperazines; Plants, Medicinal; Purines; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sleep Initiation and Maintenance Disorders; Sulfones; Testosterone; Time Factors; Treatment Outcome; Vasodilator Agents | 2006 |
Cost-utility of selective serotonin reuptake inhibitors for depression in primary care in Catalonia.
Topics: Adolescent; Adult; Aged; Catchment Area, Health; Citalopram; Cost-Benefit Analysis; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluoxetine; Health Expenditures; Humans; Male; Middle Aged; Paroxetine; Primary Health Care; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Spain | 2006 |
Treatment of postpsychotic depression with sertraline in patients with schizophrenia.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Female; Humans; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline | 2006 |
Cost-utility comparison of escitalopram and sertraline in the treatment of major depressive disorder.
Topics: Adult; Antidepressive Agents; Citalopram; Cost-Benefit Analysis; Decision Support Techniques; Depressive Disorder; Diarrhea; Drug Costs; Erectile Dysfunction; Female; Headache; Humans; Male; Monte Carlo Method; Nausea; Office Visits; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Initiation and Maintenance Disorders | 2007 |
Antidepressant activity of beta-lactam antibiotics and their effects on the severity of serotonin edema.
Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Depressive Disorder; Drug Combinations; Edema; Exploratory Behavior; Imipenem; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Serotonin; Sertraline; Statistics, Nonparametric | 2006 |
Use of antidepressants for depression in patients with advanced cancer.
Topics: Antidepressive Agents; Depressive Disorder; Humans; Neoplasms; Quality of Life; Sertraline; Survival Rate | 2007 |
Sertraline and hyperpigmentation: a case report.
Topics: Antidepressive Agents; Depressive Disorder; Female; Humans; Hyperpigmentation; Middle Aged; Sertraline | 2007 |
Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST).
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Male; Mice; Mice, Knockout; Motor Activity; Paroxetine; Receptors, Dopamine D3; Selective Serotonin Reuptake Inhibitors; Sertraline; Species Specificity; Swimming | 2008 |
Trends in antidepressant use in the older population: results from the LASA-study over a period of 10 years.
Topics: Adult; Age Distribution; Age Factors; Aged; Antidepressive Agents; Citalopram; Cognition Disorders; Comorbidity; Depressive Disorder; Depressive Disorder, Major; Disability Evaluation; Drug Utilization; Geriatric Assessment; Humans; Longitudinal Studies; Middle Aged; Multivariate Analysis; Netherlands; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 2008 |
Lymphocyte glucocorticoid receptor: predictor of sertraline response in adolescent major depressive disorder (MDD).
Topics: 1-Naphthylamine; Adolescent; Binding Sites; Depressive Disorder; Humans; Lymphocytes; Receptors, Glucocorticoid; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1995 |
Suspected congenital sertraline dependence.
Topics: 1-Naphthylamine; Antidepressive Agents; Breast Feeding; Depressive Disorder; Female; Humans; Infant, Newborn; Male; Neonatal Abstinence Syndrome; Pregnancy; Pregnancy Complications; Sertraline | 1995 |
The effect of tianeptine and sertraline in three animal models of depression.
Topics: 1-Naphthylamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Behavior, Animal; Body Temperature; Corticosterone; Depressive Disorder; Hydroxyindoleacetic Acid; Hypothalamus; Indoles; Male; Motor Activity; Neurotransmitter Agents; Olfactory Bulb; Rats; Rats, Sprague-Dawley; Sertraline; Thiazepines | 1994 |
Sertraline for chronic obstructive pulmonary disease and comorbid anxiety and mood disorders.
Topics: 1-Naphthylamine; Anxiety Disorders; Comorbidity; Depressive Disorder; Humans; Lung Diseases, Obstructive; Panic Disorder; Prevalence; Selective Serotonin Reuptake Inhibitors; Sertraline | 1995 |
Re: A treatment for impulse control disorders.
Topics: 1-Naphthylamine; Depressive Disorder; Disruptive, Impulse Control, and Conduct Disorders; Humans; Male; Pedophilia; Selective Serotonin Reuptake Inhibitors; Sertraline; Trichotillomania | 1995 |
SIADH associated with sertraline therapy.
Topics: 1-Naphthylamine; Aged; Depressive Disorder; Drinking; Female; Humans; Inappropriate ADH Syndrome; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Sodium | 1995 |
SIADH associated with fluoxetine and sertraline therapy.
Topics: 1-Naphthylamine; Age Factors; Aged; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Inappropriate ADH Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Sodium | 1995 |
Attenuation of response to serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Adult; Depressive Disorder; Drug Therapy, Combination; Drug Tolerance; Female; Fluoxetine; Humans; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline | 1995 |
Breastfeeding and sertraline: a 24-hour analysis.
Topics: 1-Naphthylamine; Adult; Breast Feeding; Child Development; Depressive Disorder; Female; Humans; Infant, Newborn; Milk, Human; Neonatal Screening; Nortriptyline; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors | 1995 |
Effects of long term treatment with sertraline (Zoloft) simulating hypothyroidism in an adolescent.
Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Depressive Disorder; Diagnosis, Differential; Humans; Hypothyroidism; Male; Recurrence; Sertraline; Thyroid Function Tests; Thyroxine | 1995 |
A treatment for impulse control disorders and paraphilia: a case report.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Depressive Disorder; Follow-Up Studies; Humans; Incest; Libido; Male; Marriage; Pedophilia; Selective Serotonin Reuptake Inhibitors; Sertraline; Trichotillomania | 1995 |
An alert to extrapyramidal side-effects from SSRIs.
Topics: 1-Naphthylamine; Aged; Akathisia, Drug-Induced; Antidepressive Agents; Depressive Disorder; Dystonia; Female; Humans; Neurologic Examination; Selective Serotonin Reuptake Inhibitors; Sertraline | 1995 |
Treatment of sexual side effects with dopaminergic agents.
Topics: 1-Naphthylamine; Adult; Depressive Disorder; Dopamine Agents; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological | 1995 |
Priapism with sertraline and lithium.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Lithium Carbonate; Male; Penile Erection; Priapism; Sertraline | 1994 |
Sertraline and speech blockage.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Anxiety Disorders; Depressive Disorder; Dose-Response Relationship, Drug; Dysarthria; Humans; Male; Sertraline; Verbal Behavior | 1994 |
Sertraline and akathisia.
Topics: 1-Naphthylamine; Akathisia, Drug-Induced; Arousal; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Middle Aged; Neurologic Examination; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
LSD flashback syndrome exacerbated by selective serotonin reuptake inhibitor antidepressants in adolescents.
Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Depressive Disorder; Drug Interactions; Female; Humans; Lysergic Acid Diethylamide; Male; Paroxetine; Recurrence; Sertraline; Substance-Related Disorders; Syndrome | 1994 |
Treatment of dysthymia with sertraline.
Topics: 1-Naphthylamine; Adult; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Breast tenderness and enlargement induced by sertraline.
Topics: 1-Naphthylamine; Adult; Aged; Breast Diseases; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Hypertrophy; Pain; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Sertraline-induced stuttering.
Topics: 1-Naphthylamine; Caffeine; Depressive Disorder; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Stuttering | 1994 |
Acidophilus for sertraline-induced diarrhea.
Topics: 1-Naphthylamine; Adult; Depressive Disorder; Diarrhea; Female; Humans; Lactobacillus acidophilus; Selective Serotonin Reuptake Inhibitors; Sertraline; Yogurt | 1994 |
Galactorrhea induced by sertraline.
Topics: 1-Naphthylamine; Adult; Depressive Disorder; Female; Galactorrhea; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline | 1993 |
Erythema multiforme and angioedema with indapamide and sertraline.
Topics: 1-Naphthylamine; Angioedema; Antidepressive Agents; Depressive Disorder; Drug Eruptions; Drug Interactions; Erythema Multiforme; Female; Humans; Hypertension; Indapamide; Middle Aged; Sertraline | 1994 |
Association of transient SIADH with sertraline.
Topics: 1-Naphthylamine; Carbamazepine; Depressive Disorder; Drug Therapy, Combination; Drug Tolerance; Humans; Inappropriate ADH Syndrome; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Mania induced by sertraline in a prepubertal child.
Topics: 1-Naphthylamine; Bipolar Disorder; Child; Depressive Disorder; Female; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
An interaction of sertraline and desipramine.
Topics: 1-Naphthylamine; Depressive Disorder; Desipramine; Drug Interactions; Drug Therapy, Combination; Female; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline | 1993 |
Sertraline in the treatment of bulimia nervosa.
Topics: 1-Naphthylamine; Adult; Bulimia; Depressive Disorder; Female; Humans; Phobic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline | 1993 |
Effect of chronic antidepressant treatment on responses to apomorphine in selectively bred rat strains.
Topics: 1-Naphthylamine; Animals; Apomorphine; Body Temperature Regulation; Breeding; Depressive Disorder; Desipramine; Disease Models, Animal; Male; Motor Activity; Parasympathetic Nervous System; Rats; Sertraline; Time Factors | 1993 |
Tolerance to fluoxetine.
Topics: 1-Naphthylamine; Adult; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Tolerance; Female; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline | 1993 |
Akathisia and sertraline.
Topics: 1-Naphthylamine; Adult; Akathisia, Drug-Induced; Depressive Disorder; Female; Humans; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide | 1993 |
Lithium augmentation in sertraline-resistant depression: a preliminary dose-response study.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline | 1993 |
SSRI-associated nocturnal bruxism in four patients.
Topics: 1-Naphthylamine; Adult; Bruxism; Buspirone; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep | 1993 |
Sertraline and extrapyramidal side effects.
Topics: 1-Naphthylamine; Adult; Akathisia, Drug-Induced; Basal Ganglia Diseases; Depressive Disorder; Dystonia; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Interactions between sertraline and tricyclic antidepressants.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Tricyclic; Depressive Disorder; Desipramine; Drug Interactions; Humans; Imipramine; Male; Selective Serotonin Reuptake Inhibitors; Sertraline | 1993 |
Paradoxical sedation with sertraline.
Topics: 1-Naphthylamine; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep | 1993 |
Sertraline-induced akathisia.
Topics: 1-Naphthylamine; Akathisia, Drug-Induced; Arousal; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Middle Aged; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline | 1993 |
Hyponatremia in a patient treated with sertraline.
Topics: 1-Naphthylamine; Aged; Depressive Disorder; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Selective Serotonin Reuptake Inhibitors; Sertraline | 1993 |
Case report of probable sertraline-induced akathisia.
Topics: 1-Naphthylamine; Adult; Akathisia, Drug-Induced; Depressive Disorder; Female; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline | 1993 |
Burning mouth syndrome. Successful treatment with combined psychotherapy and psychopharmacotherapy.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Burning Mouth Syndrome; Combined Modality Therapy; Depressive Disorder; Female; Humans; Life Change Events; Psychoanalytic Therapy; Sertraline | 1995 |
Sertraline for body dysmorphic disorder.
Topics: 1-Naphthylamine; Adolescent; Depressive Disorder; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Somatoform Disorders | 1995 |
Sertraline-induced exacerbation of tics in Tourette's syndrome.
Topics: 1-Naphthylamine; Adolescent; Depressive Disorder; Female; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Tic Disorders; Tourette Syndrome | 1995 |
SSRI-induced mania.
Topics: 1-Naphthylamine; Adolescent; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Treatment of late-onset agoraphobia secondary to depression.
Topics: 1-Naphthylamine; Adaptation, Psychological; Aged; Aged, 80 and over; Agoraphobia; Antidepressive Agents; Depressive Disorder; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Nortriptyline; Sertraline; Sick Role | 1995 |
Severe hyponatraemia associated with selective serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Depressive Disorder; Female; Fluoxetine; Humans; Hyponatremia; Referral and Consultation; Selective Serotonin Reuptake Inhibitors; Sertraline | 1995 |
Stuttering with sertraline.
Topics: 1-Naphthylamine; Adult; Depressive Disorder; Female; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Stuttering | 1996 |
Successful treatment of transvestic fetishism with sertraline and lithium.
Topics: 1-Naphthylamine; Adult; Comorbidity; Depressive Disorder; Drug Therapy, Combination; Fetishism, Psychiatric; Humans; Lithium Carbonate; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Transvestism; Treatment Outcome | 1996 |
Prolonged bleeding time in a patient treated with sertraline.
Topics: 1-Naphthylamine; Adolescent; Bleeding Time; Blood Coagulation Disorders; Depressive Disorder; Ecchymosis; Female; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Seizure and transient SIADH associated with sertraline.
Topics: 1-Naphthylamine; Adult; Depressive Disorder; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Seizures; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Sertraline in the treatment of neurotic excoriations and related disorders.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Depressive Disorder; Female; Humans; Male; Mental Disorders; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Skin Diseases | 1996 |
Drug-drug interactions.
Topics: 1-Naphthylamine; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Mixed Function Oxygenases; Paroxetine; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Fluoxetine associated paresthesias and alopecia in a woman who tolerated sertraline.
Topics: 1-Naphthylamine; Adult; Alopecia; Depressive Disorder; Female; Fluoxetine; Humans; Paresthesia; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Selective serotonin reuptake inhibitors and SIADH. Adverse Drug Reactions Advisory Committee.
Topics: 1-Naphthylamine; Aged; Depressive Disorder; Female; Humans; Inappropriate ADH Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Delirium associated with a combination of sertraline, haloperidol, and benztropine.
Topics: 1-Naphthylamine; Adult; Benztropine; Delirium; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Haloperidol; Humans; Lithium; Parkinson Disease, Secondary; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Incentive bias?
Topics: 1-Naphthylamine; Clinical Trials as Topic; Depressive Disorder; Drug Administration Schedule; Drug Costs; Drug Industry; Financial Support; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Sertraline-associated hyponatremia.
Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Depressive Disorder; Humans; Hyponatremia; Male; Selective Serotonin Reuptake Inhibitors; Sertraline | 1995 |
Treating depression among alcoholics.
Topics: 1-Naphthylamine; Adult; Alcoholism; Antidepressive Agents; Combined Modality Therapy; Comorbidity; Depressive Disorder; Humans; Male; Personality Inventory; Sertraline | 1996 |
Sertraline withdrawal in two brothers: a case report.
Topics: 1-Naphthylamine; Adult; Depressive Disorder; Dizziness; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome | 1996 |
Review of clinical use of sertraline by family practice physicians in a small Air Force hospital.
Topics: 1-Naphthylamine; Antidepressive Agents; Depressive Disorder; Drug Utilization; Family Practice; Hospitals, Military; Humans; Retrospective Studies; Sertraline; United States | 1996 |
DSM-IV and sexuality.
Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Body Image; Depressive Disorder; Humans; Male; Psychiatric Status Rating Scales; Sertraline; Sexual Behavior | 1996 |
More on SSRI-induced mania.
Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Sertraline | 1996 |
A comparison of the cost-effectiveness of sertraline versus tricyclic antidepressants in primary care.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Tricyclic; Cost-Benefit Analysis; Depressive Disorder; Family Practice; Female; Humans; Male; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index | 1996 |
SSRI and sexual functioning.
Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Depressive Disorder; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological | 1996 |
Antidepressants in pregnancy and breastfeeding.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Breast Feeding; Depressive Disorder; Female; Humans; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Sertraline | 1995 |
Withdrawal syndromes after paroxetine and sertraline discontinuation.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome | 1995 |
A case of sertraline-induced stuttering.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Depressive Disorder; Female; Humans; Sertraline; Stuttering | 1996 |
Sertraline and galactorrhea.
Topics: 1-Naphthylamine; Adult; Depressive Disorder; Female; Galactorrhea; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Effect of valine on 5-HT neurotransmission and mood.
Topics: 1-Naphthylamine; Adult; Affect; Amino Acids, Branched-Chain; Amitriptyline; Analysis of Variance; Antidepressive Agents; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Female; Fenfluramine; Humans; Lithium; Male; Paroxetine; Prolactin; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Synaptic Transmission; Valine | 1996 |
Selective serotonin reuptake inhibitors (SSRIs) in the treatment of elderly depressed patients: a qualitative analysis of the literature on their efficacy and side-effects.
Topics: 1-Naphthylamine; Aged; Anorexia; Antidepressive Agents; Depressive Disorder; Diarrhea; Fluoxetine; Fluvoxamine; Humans; Meta-Analysis as Topic; Nausea; Paroxetine; Patient Dropouts; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method | 1996 |
Spontaneous orgasm with the combined use of bupropion and sertraline.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Second-Generation; Bupropion; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Orgasm; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Coadministration of isoniazid and antidepressant drugs.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Comorbidity; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Humans; Isoniazid; Sertraline; Tuberculosis | 1996 |
Comment: Serotonin syndrome associated with combined sertraline-amitriptyline treatment.
Topics: 1-Naphthylamine; Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Depressive Disorder; Drug Interactions; Female; Humans; Nervous System Diseases; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Patient prescribed sertraline charged with driving under the influence.
Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Automobile Driving; Depressive Disorder; Humans; Male; Sertraline; Social Control, Formal | 1997 |
Dystonia associated with trazodone and sertraline.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dystonia; Humans; Male; Pain, Intractable; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Trazodone | 1997 |
Inability to cry during SRI treatment.
Topics: 1-Naphthylamine; Adult; Crying; Depressive Disorder; Emotions; Female; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors | 1996 |
Mandibular dystonia associated with the combination of sertraline and metoclopramide.
Topics: 1-Naphthylamine; Adult; Basal Ganglia Diseases; Depressive Disorder; Drug Interactions; Dystonia; Female; Gastroesophageal Reflux; Humans; Mandible; Metoclopramide; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Sertraline and akathisia: spontaneous resolution.
Topics: 1-Naphthylamine; Adult; Akathisia, Drug-Induced; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Neurologic Examination; Obsessive-Compulsive Disorder; Remission, Spontaneous; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Dexamethasone augmentation in treatment-resistant depression.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Dexamethasone; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Middle Aged; Personality Inventory; Pituitary-Adrenal System; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
SSRI optimal dose remains at issue.
Topics: 1-Naphthylamine; Clinical Trials as Topic; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
Sertraline-induced anorgasmia treated with intermittent nefazodone.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Male; Orgasm; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Triazoles | 1997 |
Recurrent hyponatremia associated with sertraline and lofepramine.
Topics: 1-Naphthylamine; Aged; Antidepressive Agents, Tricyclic; Depressive Disorder; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lofepramine; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Sertraline and norsertraline levels in three breastfed infants.
Topics: 1-Naphthylamine; Breast Feeding; Depressive Disorder; Female; Humans; Infant, Newborn; Puerperal Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Psychotic mania associated with fenfluramine and phentermine use.
Topics: 1-Naphthylamine; Bipolar Disorder; Depressive Disorder; Female; Fenfluramine; Humans; Middle Aged; Obesity, Morbid; Phentermine; Sertraline | 1997 |
Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy.
Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Anxiety Disorders; Bupropion; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Dysthymic Disorder; Epilepsy; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
Channeling of three newly introduced antidepressants to patients not responding satisfactorily to previous treatment.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Drug Resistance; Drug Utilization; Humans; Mianserin; Middle Aged; Mirtazapine; Netherlands; Sertraline; Venlafaxine Hydrochloride | 1997 |
Psychiatrists' responses to failure of maintenance therapy with antidepressants.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Attitude of Health Personnel; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium; Male; Nortriptyline; Recurrence; Sertraline; Treatment Failure | 1997 |
The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia.
Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Depressive Disorder; Female; Humans; Male; Paroxetine; Psychotic Disorders; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Reversible parkinsonism in a 90-year-old man taking sertraline.
Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Parkinson Disease, Secondary; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Anxiety and mood disorders associated with gonadotropin-releasing hormone agonist therapy.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Antineoplastic Agents, Hormonal; Anxiety Disorders; Depressive Disorder; Endometriosis; Female; Humans; Leuprolide; Sertraline | 1997 |
An open study of the effects of sertraline on adolescent major depression.
Topics: 1-Naphthylamine; Adolescent; Depressive Disorder; Female; Humans; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series.
Topics: 1-Naphthylamine; Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Chemotherapy, Adjuvant; Child; Depressive Disorder; Female; Fluoxetine; Humans; Male; Methylphenidate; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Sertraline and desmethylsertraline in human breast milk and nursing infants.
Topics: 1-Naphthylamine; Breast Feeding; Depression, Postpartum; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Infant, Newborn; Lactation; Milk, Human; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Buspirone augmentation of a selective serotonin reuptake inhibitor: efficacy in two depressed patients with comorbid anxiety and type I alcohol dependence.
Topics: 1-Naphthylamine; Adult; Alcoholism; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Buspirone; Comorbidity; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
Case study: ego-dystonic anger attacks in mothers of young children.
Topics: 1-Naphthylamine; Adult; Anger; Antidepressive Agents; Child Abuse; Child, Preschool; Depressive Disorder; Female; Humans; Male; Sertraline | 1997 |
Effect of sertraline on plasma nortriptyline levels in depressed elderly.
Topics: 1-Naphthylamine; Aged; Depressive Disorder; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nortriptyline; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Concomitant use of selective serotonin reuptake inhibitors with other cytochrome P450 2D6 or 3A4 metabolized medications: how often does it really happen?
Topics: 1-Naphthylamine; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Liver; Metabolic Clearance Rate; Mixed Function Oxygenases; Paroxetine; Psychotropic Drugs; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Serotonin, cigarettes, and nausea.
Topics: 1-Naphthylamine; Adult; Depressive Disorder; Drug Interactions; Female; Humans; Narcolepsy; Nausea; Nicotine; Selective Serotonin Reuptake Inhibitors; Sertraline; Smoking | 1997 |
Sertraline for premenstrual dysphoric disorder.
Topics: 1-Naphthylamine; Antidepressive Agents; Depressive Disorder; Female; Fluoxetine; Humans; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Tricyclic antidepressant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: a multivariate analysis.
Topics: 1-Naphthylamine; Antidepressive Agents, Tricyclic; Depressive Disorder; Direct Service Costs; Drug Costs; Fee-for-Service Plans; Female; Fluoxetine; Health Care Costs; Humans; Insurance Claim Review; Insurance, Pharmaceutical Services; Male; Models, Econometric; Multivariate Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 1998 |
Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush Sexual Inventory.
Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior | 1997 |
Selective serotonin reuptake inhibitor modulation of clozapine effects on cognition in schizophrenia.
Topics: 1-Naphthylamine; Adult; Antipsychotic Agents; Clozapine; Cognition; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Fluoxetine; Humans; Male; Neuropsychological Tests; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Serum sertraline and N-desmethylsertraline levels in breast-feeding mother-infant pairs.
Topics: 1-Naphthylamine; Breast Feeding; Depressive Disorder; Female; Humans; Infant; Infant, Newborn; Lactation; Male; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
[Choice of therapeutic tactics in treatment of endogenous depression by means of statusmetric expert system].
Topics: 1-Naphthylamine; Amitriptyline; Antidepressive Agents, Tricyclic; Depressive Disorder; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 1997 |
The SSRI antidepressants: exploring their "other" possible properties.
Topics: 1-Naphthylamine; Adult; Aged; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires | 1998 |
Survivors of torture presenting at an anxiety disorders clinic: symptomatology and pharmacotherapy.
Topics: 1-Naphthylamine; Adolescent; Adult; Antidepressive Agents; Anxiety Disorders; Comorbidity; Depressive Disorder; Female; Humans; Imipramine; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; South Africa; Survivors; Torture; Treatment Outcome | 1998 |
Sertraline for the treatment of depression in Parkinson's disease.
Topics: 1-Naphthylamine; Aged; Antidepressive Agents; Depressive Disorder; Humans; Parkinson Disease; Personality Assessment; Sertraline; Treatment Outcome | 1998 |
Sertraline discontinuation syndrome presenting with severe depression and compulsions.
Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Depressive Disorder; Humans; Middle Aged; Sertraline; Substance Withdrawal Syndrome | 1998 |
Black and white patients response to antidepressant treatment for major depression.
Topics: 1-Naphthylamine; Adult; Ambulatory Care; Antidepressive Agents, Tricyclic; Black People; Body Weight; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Length of Stay; Male; Middle Aged; Pharmacogenetics; Psychiatric Status Rating Scales; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Treatment Outcome; White People | 1998 |
Selective serotonin reuptake inhibitor discontinuation with ECT and withdrawal symptoms.
Topics: 1-Naphthylamine; Antidepressive Agents; Depressive Disorder; Diagnosis, Differential; Electroconvulsive Therapy; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome | 1998 |
Platelet serotonin transporter in depressed children and adolescents: 3H-paroxetine platelet binding before and after sertraline.
Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Blood Platelets; Carrier Proteins; Child; Depressive Disorder; Female; Humans; Kinetics; Male; Paroxetine; Serotonin; Sertraline | 1998 |
Hypomania associated with mirtazapine augmentation of sertraline.
Topics: 1-Naphthylamine; Ambulatory Care; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Dysthymic Disorder; Female; Humans; Mianserin; Middle Aged; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Extrapyramidal adverse effects associated with sertraline.
Topics: Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Basal Ganglia Diseases; Depressive Disorder; Humans; Male; Middle Aged; Sertraline; Tremor | 1998 |
Antidepressants in depressed patients with irritable bowel syndrome.
Topics: Acute Disease; Adult; Antidepressive Agents, Second-Generation; Bupropion; Colonic Diseases, Functional; Comorbidity; Depressive Disorder; Female; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Use of psychotropic medications during lactation.
Topics: Breast Feeding; Depressive Disorder; Female; Humans; Infant, Newborn; Lactation; Milk, Human; Psychotropic Drugs; Sertraline; Terminology as Topic | 1998 |
Priapism in a patient taking sertraline.
Topics: Attention Deficit Disorder with Hyperactivity; Depressive Disorder; Humans; Male; Middle Aged; Priapism; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Discontinuation of antidepressant therapy: emerging complications and their relevance.
Topics: Antidepressive Agents; Depressive Disorder; Fluoxetine; Humans; Paroxetine; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome; Syndrome; Terminology as Topic | 1998 |
The role of culture in psychiatric care.
Topics: Culture; Depressive Disorder; Female; Hispanic or Latino; Humans; Middle Aged; Patient Compliance; Psychotherapy; Religion and Psychology; Selective Serotonin Reuptake Inhibitors; Sertraline; Somatoform Disorders | 1998 |
Sertraline-induced hyponatremia in an older patient.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Dementia; Depressive Disorder; Humans; Hyponatremia; Male; Sertraline | 1998 |
Sildenafil citrate for SSRI-induced sexual side effects.
Topics: Adult; Depressive Disorder; Enzyme Inhibitors; Erectile Dysfunction; Humans; Male; Orgasm; Piperazines; Purines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sulfones | 1999 |
St. John's wort and hypomania.
Topics: Antipsychotic Agents; Bipolar Disorder; Depressive Disorder; Ericales; Female; Food, Organic; Humans; Middle Aged; Panic Disorder; Phytotherapy; Sertraline | 1998 |
Trends in the use of selective serotonin reuptake inhibitors in nine Department of Veterans Affairs outpatient facilities.
Topics: Depressive Disorder; Drug Costs; Drug Prescriptions; Fluoxetine; Hospitals, Veterans; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1999 |
Fluoxetine and sertraline dosages in major depression.
Topics: Depressive Disorder; Dose-Response Relationship, Drug; Fluoxetine; Humans; Retrospective Studies; Sertraline | 1999 |
SSRI antidepressant drug use patterns in the naturalistic setting: a multivariate analysis.
Topics: Adult; Databases, Factual; Depressive Disorder; Drug Utilization; Episode of Care; Female; Fluoxetine; Humans; Logistic Models; Male; Multivariate Analysis; Paroxetine; Psychotherapy; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 1999 |
A cautionary tale.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Diagnosis, Differential; Female; Humans; Psychophysiologic Disorders; Sertraline; Weight Loss | 1999 |
Selective serotonin reuptake inhibitors and delusional depression.
Topics: Comorbidity; Delusions; Depressive Disorder; Humans; Paroxetine; Psychiatric Status Rating Scales; Psychometrics; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1999 |
Relapse of depressive symptoms after discontinuing sertraline.
Topics: Antidepressive Agents; Chronic Disease; Depressive Disorder; Humans; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline | 1999 |
Excretion of paroxetine into breast milk.
Topics: Adult; Breast Feeding; Citalopram; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Fluvoxamine; Humans; Lactation; Milk, Human; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Triglycerides | 1999 |
Economic appraisal of citalopram in the management of single-episode depression.
Topics: Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cohort Studies; Cost-Benefit Analysis; Depressive Disorder; Female; Fluoxetine; Health Maintenance Organizations; Humans; Male; Middle Aged; Paroxetine; Patient Care Team; Retrospective Studies; Sertraline | 1999 |
Course and cost of treatment for depression with fluoxetine, paroxetine, and sertraline.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Cost of Illness; Cost-Benefit Analysis; Depressive Disorder; Female; Fluoxetine; Follow-Up Studies; Health Care Costs; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 1999 |
Comparative efficacy and safety of sertraline versus nortriptyline in major depression in patients 70 and older.
Topics: Aged; Depressive Disorder; Humans; Nortriptyline; Psychiatric Status Rating Scales; Sertraline | 1999 |
Penile anesthesia associated with sertraline use.
Topics: Adjustment Disorders; Adult; Depressive Disorder; Humans; Hypesthesia; Male; Penile Diseases; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunction, Physiological | 1999 |
Sertraline in the treatment of minor depression in nursing home residents: a pilot study.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Depressive Disorder; Female; Frail Elderly; Homes for the Aged; Humans; Male; Nursing Homes; Pilot Projects; Sertraline; Treatment Outcome | 2000 |
Exercise as an effective treatment option for major depression in older adults.
Topics: Aged; Antidepressive Agents; Combined Modality Therapy; Depressive Disorder; Exercise; Humans; Jogging; Middle Aged; Randomized Controlled Trials as Topic; Reproducibility of Results; Sertraline; Treatment Outcome; Walking | 2000 |
Mania in a patient receiving testosterone replacement postorchidectomy taking St John's wort and sertraline.
Topics: Administration, Oral; Adult; Antidepressive Agents; Arousal; Bipolar Disorder; Cryptorchidism; Depressive Disorder; Humans; Hypericum; Male; Orchiectomy; Plants, Medicinal; Postoperative Complications; Sertraline; Testosterone | 2000 |
[The effectiveness of sertraline (zoloft) in the therapy of maladaptation in the outpatient setting].
Topics: Adaptation, Psychological; Adult; Ambulatory Care; Depressive Disorder; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2000 |
[Hyponatremia and sertraline].
Topics: Antidepressive Agents; Depressive Disorder; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline | 2000 |
Newer antidepressants: a comparison of tolerability in general practice.
Topics: Adult; Aged; Antidepressive Agents; Cohort Studies; Cyclohexanols; Depressive Disorder; Family Practice; Female; Fluoxetine; Humans; Male; Middle Aged; Moclobemide; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride | 1999 |
Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.
Topics: Adult; Cyclohexanols; Depressive Disorder; Female; Humans; Libido; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Ontario; Orgasm; Paroxetine; Prevalence; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Sexual Dysfunctions, Psychological; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
Lack of sertraline efficacy probably due to an interaction with carbamazepine.
Topics: Adult; Anticonvulsants; Carbamazepine; Depressive Disorder; Drug Administration Schedule; Drug Interactions; Female; Humans; Male; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Treatment Outcome | 2000 |
Sertraline treatment of interferon-alfa-induced depressive disorder.
Topics: Adult; Depressive Disorder; Female; Hepatitis C; Humans; Interferon-alpha; Irritable Mood; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline | 2000 |
Venlafaxine versus sertraline for major depressive disorder.
Topics: Ambulatory Care; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Humans; Randomized Controlled Trials as Topic; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
Effects of reboxetine and sertraline treatments alone and in combination on the binding properties of cortical NMDA and beta1-adrenergic receptors in an animal model of depression.
Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Animals; Cerebral Cortex; Depressive Disorder; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Kynurenic Acid; Male; Morpholines; Neurons; Norepinephrine; Propanolamines; Rats; Rats, Sprague-Dawley; Reboxetine; Receptors, Adrenergic, beta-1; Receptors, N-Methyl-D-Aspartate; Serotonin; Sertraline | 2000 |
Serotonergic antidepressants and urinary incontinence.
Topics: Adult; Bipolar Disorder; Cyclohexanols; Depressive Disorder; Female; Humans; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Urinary Incontinence; Venlafaxine Hydrochloride | 2000 |
Fluoxetine (Sarafem) for premenstrual dysphoric disorder.
Topics: Adult; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoxetine; Humans; Nausea; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride; Weight Gain | 2001 |
Serotonin syndrome following low-dose sertraline.
Topics: Adult; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Serotonin Syndrome; Sertraline | 2000 |
Psychotic depression, subcortical arteriosclerotic encephalopathy and holocaust-conditioned posttraumatic stress disorder.
Topics: Aged; Dementia, Vascular; Depressive Disorder; Female; Holocaust; Humans; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Stress Disorders, Post-Traumatic | 2001 |
Platelet function and sertraline.
Topics: Depressive Disorder; Humans; Platelet Activation; Receptors, Serotonin; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Smoking | 2001 |
Economic evaluation of major selective serotonin-reuptake inhibitors in a managed care population.
Topics: Adolescent; Adult; Depressive Disorder; Drug Costs; Episode of Care; Fluoxetine; Humans; Managed Care Programs; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 2001 |
SSRI discontinuation and buspirone.
Topics: Acute Disease; Buspirone; Depressive Disorder; Down-Regulation; Female; Humans; Middle Aged; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Substance Withdrawal Syndrome; Syndrome | 2001 |
Fluvoxamine but not sertraline inhibits the metabolism of olanzapine: evidence from a therapeutic drug monitoring service.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Benzodiazepines; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Depressive Disorder; Drug Interactions; Drug Monitoring; Female; Fluvoxamine; Humans; Liver; Male; Middle Aged; Olanzapine; Pirenzepine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2001 |
Serotonin reuptake inhibitor antidepressants and pregnancy: many unanswered questions.
Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Child; Child, Preschool; Clinical Trials as Topic; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Humans; Infant; Infant, Newborn; Paroxetine; Pregnancy; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1999 |
Dose-response relationship of selective serotonin reuptake inhibitors treatment-emergent hypomania in depressive disorders.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Paroxetine; Sertraline | 2001 |
Gender differences in treatment response.
Topics: Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive Disorder; Female; Humans; Imipramine; Male; Menopause; Numerical Analysis, Computer-Assisted; Patient Dropouts; Proportional Hazards Models; Regression Analysis; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Survival Analysis; Treatment Outcome | 2001 |
[Sertraline in child and adolescent psychiatry].
Topics: Adolescent; Anxiety Disorders; Child; Depressive Disorder; Drug Administration Schedule; Female; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Surveys and Questionnaires | 2001 |
Progress in the battle with the black dog: advances in the treatment of depression.
Topics: Antidepressive Agents; Clinical Trials as Topic; Comorbidity; Depression, Postpartum; Depressive Disorder; Drug Therapy, Combination; Erectile Dysfunction; Female; Humans; Male; Milk, Human; Piperazines; Purines; Sertraline; Sildenafil Citrate; Sulfones; Treatment Outcome; Triiodothyronine | 2001 |
Diagnosing and treating depression in the elderly.
Topics: Age Factors; Age of Onset; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Cognition; Depressive Disorder; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Nortriptyline; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2001 |
Sertralilne, paroxetine and venlafaxine in refugee post traumatic stress disorder with depression symptoms.
Topics: Adult; Antidepressive Agents; Bosnia and Herzegovina; Cyclohexanols; Depressive Disorder; Female; Humans; Male; Middle Aged; Paroxetine; Pilot Projects; Refugees; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; United States; Venlafaxine Hydrochloride; Warfare | 2001 |
Serotonin syndrome caused by selective serotonin reuptake-inhibitors-metoclopramide interaction.
Topics: Accidental Falls; Adult; Aged; Basal Ganglia Diseases; Cyclohexanols; Depressive Disorder; Dopamine Antagonists; Drug Interactions; Female; Humans; Metoclopramide; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline; Tibial Fractures; Venlafaxine Hydrochloride | 2002 |
Duration of therapy and health care costs of fluoxetine, paroxetine, and sertraline in 6 health plans.
Topics: Adolescent; Adult; Depressive Disorder; Drug Administration Schedule; Drug Costs; Female; Fluoxetine; Health Care Costs; Health Maintenance Organizations; Humans; Insurance, Pharmaceutical Services; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors | 2002 |
Placebo in clinical trials for depression: complexity and necessity.
Topics: Antidepressive Agents; Clinical Trials as Topic; Control Groups; Depressive Disorder; Hypericum; Placebo Effect; Plant Extracts; Sertraline | 2002 |
Methylphenidate in a patient with depression and respiratory insufficiency.
Topics: Aged; Antidepressive Agents; Central Nervous System Stimulants; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Male; Methylphenidate; Respiratory Insufficiency; Sertraline | 2001 |
Hyponatremia associated with sertraline and fluoxetine: a case report.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Second-Generation; Depressive Disorder; Fluoxetine; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2002 |
Are paroxetine, fluoxetine, and sertraline equally effective for depression?
Topics: Adult; Depressive Disorder; Evidence-Based Medicine; Fluoxetine; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Effects of sertraline treatment on plasma cortisol, prolactin and thyroid hormones in female depressed patients.
Topics: Antidepressive Agents; Case-Control Studies; Depressive Disorder; Female; Humans; Hydrocortisone; Middle Aged; Prolactin; Selective Serotonin Reuptake Inhibitors; Sertraline; Thyroid Hormones; Thyrotropin; Thyroxine; Triiodothyronine | 2002 |
[The myocardial infarct patient. Screening for depression and treatment].
Topics: Depressive Disorder; Humans; Myocardial Infarction; Prognosis; Selective Serotonin Reuptake Inhibitors; Sertraline; Sick Role | 2002 |
Combination treatment with noradrenalin and serotonin reuptake inhibitors in resistant depression.
Topics: 1-Naphthylamine; Adult; Aged; Aged, 80 and over; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium; Male; Middle Aged; Nortriptyline; Receptors, Adrenergic; Receptors, Serotonin; Recurrence; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 1992 |
Sertraline in the prevention of depression.
Topics: 1-Naphthylamine; Cross-Cultural Comparison; Depressive Disorder; Europe; Humans; Personality Inventory; Psychometrics; Sertraline | 1992 |
Setraline in the prevention of depression.
Topics: 1-Naphthylamine; Depressive Disorder; Humans; Long-Term Care; Personality Inventory; Recurrence; Sertraline | 1992 |
Sertraline for treatment of depression.
Topics: 1-Naphthylamine; Clinical Trials as Topic; Depressive Disorder; Humans; Neurotransmitter Uptake Inhibitors; Serotonin; Sertraline | 1992 |
Clinical implications of the pharmacology of sertraline.
Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Blood Platelets; Depressive Disorder; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Neurologic Examination; Psychomotor Performance; Serotonin; Sertraline | 1991 |
Sertraline (Lustral) and paroxetine (Seroxat)--new drugs for the treatment of depression.
Topics: 1-Naphthylamine; Antidepressive Agents; Depressive Disorder; Humans; Paroxetine; Piperidines; Sertraline | 1991 |
Effects of placebo washout and dose in a comparison of sertraline and amitriptyline.
Topics: 1-Naphthylamine; Ambulatory Care; Amitriptyline; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Placebos; Research Design; Sertraline; Single-Blind Method | 1991 |
The electrocardiogram as a tool for therapeutic monitoring: a critical analysis.
Topics: 1-Naphthylamine; Aged; Amitriptyline; Antidepressive Agents; Depressive Disorder; Diagnosis, Computer-Assisted; Electrocardiography; Heart Conduction System; Humans; Research Design; Serotonin Antagonists; Sertraline | 1990 |
Hypomania induced by sertraline, a new serotonin reuptake inhibitor.
Topics: 1-Naphthylamine; Adult; Bipolar Disorder; Depressive Disorder; Humans; Male; Middle Aged; Naphthalenes; Sertraline | 1987 |